ChargePoint (CHPT) 10-Q 15 Dec 21 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 31, 2021	Nov. 30, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2021
Document Transition Report	false
Entity File Number	001-39004
Entity Registrant Name	ChargePoint Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-1747686
Entity Address, Address Line One	240 East Hacienda Avenue
Entity Address, City or Town	Campbell
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95008
City Area Code	408
Local Phone Number	841-4500
Title of 12(b) Security	Common Stock, par value $0.0001
Trading Symbol	CHPT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		331,027,104
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001777393

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Oct. 31, 2021	Jan. 31, 2021
Current assets:
Cash and cash equivalents	$ 365,491,000	$ 145,491,000
Restricted cash	400,000	400,000
Accounts receivable, net of allowance of $2,643 as of October 31, 2021 and $2,000 as of January 31, 2021	66,104,000	35,075,000
Inventories	29,893,000	33,592,000
Prepaid expenses and other current assets	32,695,000	12,074,000
Total current assets	494,583,000	226,632,000
Property and equipment, net	34,726,000	29,988,000
Intangible assets, net	142,539,000	0
Operating lease right-of-use assets	23,621,000	21,817,000
Goodwill	200,681,000	1,215,000
Other assets	5,327,000	10,468,000
Total assets	901,477,000	290,120,000
Current liabilities:
Accounts payable	32,084,000	19,784,000
Accrued and other current liabilities	76,473,000	47,162,000
Deferred revenue	58,877,000	40,934,000
Debt, current	0	10,208,000
Total current liabilities	167,434,000	118,088,000
Deferred revenue, noncurrent	62,364,000	48,896,000
Debt, noncurrent	0	24,686,000
Operating lease liabilities	23,795,000	22,459,000
Deferred tax liabilities	28,351,000	0
Common stock warrant liabilities	29,282,000	75,843,000
Other long-term liabilities	4,852,000	972,000
Total liabilities	316,078,000	290,944,000
Commitments and contingencies (Note 7)
Temporary Equity [Abstract]
Redeemable convertible preferred stock: $0.0001 par value; 0 and 185,180,248 shares authorized as of October 31, 2021 and January 31, 2021, respectively; 0 and 182,934,257 shares issued and outstanding as of October 31, 2021 and January 31, 2021, respectively (liquidation value: $— and $17,492,964 as of October 31, 2021 and January 31, 2021, respectively)	0	615,697,000
Stockholders’ equity (deficit):
Common stock: $0.0001 par value; 1,000,000,000 and 299,771,284 shares authorized as of October 31, 2021 and January 31, 2021, respectively; 330,964,104 and 22,961,032 shares issued and outstanding as of October 31, 2021 and January 31, 2021, respectively	33,000	2,000
Preferred stock, $0.0001 par value; 10,000,000 and 0 shares authorized as of October 31, 2021 and January 31, 2021, respectively; 0 issued and outstanding as of October 31, 2021 and January 31, 2021	0	0
Additional paid-in capital	1,337,247,000	62,736,000
Accumulated other comprehensive income (loss)	(376,000)	155,000
Accumulated deficit	(751,505,000)	(679,414,000)
Total stockholders’ equity (deficit)	585,399,000	(616,521,000)
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)	$ 901,477,000	$ 290,120,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)		Oct. 31, 2021	Jan. 31, 2021
Current assets:
Allowance for credit loss		$ 2,643,000	$ 2,000,000
Temporary Equity [Abstract]
Par value (USD per share)		$ 0.0001	$ 0.0001
Shares authorized (in shares)		0	185,180,248
Shares issued (in shares)		0	182,934,257
Shares outstanding (in shares)	[1]	0	182,934,257
Liquidation value		$ 0	$ 17,492,964
Stockholders’ equity (deficit):
Common stock, par value (USD per share)		$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)		1,000,000,000	299,771,284
Common Stock, shares issued (in shares)		330,964,104	22,961,032
Common Stock, shares outstanding (in shares)		330,964,104	22,961,032
Preferred stock, par value (USD per share)		$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)		10,000,000	0
Preferred stock, shares issued (in shares)		0	0
Preferred stock, shares outstanding (in shares)		0	0
[1]	The shares of the Company’s common and redeemable convertible preferred stock prior to the Merger (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.9966 established in the Merger as described in Note 3.

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Revenue
Total revenue	$ 65,034	$ 36,365	$ 161,665	$ 104,098
Cost of revenue
Total cost of revenue	48,978	29,112	125,615	80,053
Gross profit	16,056	7,253	36,050	24,045
Operating expenses
Research and development	36,751	18,919	102,535	54,071
Sales and marketing	24,361	12,134	62,258	37,301
General and administrative	20,268	8,790	57,467	18,345
Total operating expenses	81,380	39,843	222,260	109,717
Loss from operations	(65,324)	(32,590)	(186,210)	(85,672)
Interest income	25	18	72	298
Interest expense	(3)	(815)	(1,502)	(2,443)
Change in fair value of contingent earnout liability	0	0	84,420	0
Transaction costs expensed	0	0	(7,031)	0
Other (expense) income, net	(2,025)	(85)	(2,200)	46
Net loss before income taxes	(69,756)	(40,792)	(72,303)	(106,072)
Provision for (benefit from) income taxes	(314)	98	(211)	203
Net loss	(69,442)	(40,890)	(72,092)	(106,275)
Accretion of beneficial conversion feature of redeemable convertible preferred stock	0	(1,752)	0	(60,377)
Cumulative dividends on redeemable convertible preferred stock	0	(3,960)	(4,292)	(3,960)
Deemed dividends attributable to vested option holders	0	0	(51,855)	0
Deemed dividends attributable to common stock warrant holders	0	0	(110,635)	0
Net loss attributable to common stockholders - Basic	(69,442)	(46,602)	(238,874)	(170,612)
Gain attributable to earnout shares issued	0	0	(84,420)	0
Change in fair value of dilutive warrants	0	0	(51,106)	0
Net loss attributable to common stockholders - Diluted	$ (69,442)	$ (46,602)	$ (374,400)	$ (170,612)
Weighted average shares outstanding - Basic (in shares)	325,034,920	14,990,866	286,025,483	13,550,552
Weighted average shares outstanding - Diluted (in shares)	325,034,920	14,990,866	292,575,318	13,550,552
Net loss per share - Basic (USD per share)	$ (0.21)	$ (3.11)	$ (0.84)	$ (12.59)
Net loss per share - Diluted (USD per share)	$ (0.21)	$ (3.11)	$ (1.28)	$ (12.59)
Redeemable convertible preferred stock warrant liability
Operating expenses
Change in fair value of warrant liabilities	$ 0	$ (7,320)	$ 9,237	$ (18,301)
Common Stock Warrant Liability
Operating expenses
Change in fair value of warrant liabilities	(2,429)	0	30,911	0
Networked charging systems
Revenue
Total revenue	47,511	22,566	115,185	63,591
Cost of revenue
Total cost of revenue	38,720	22,382	97,846	61,406
Subscriptions
Revenue
Total revenue	13,397	10,782	36,303	29,597
Cost of revenue
Total cost of revenue	7,637	5,322	21,107	14,547
Other
Revenue
Total revenue	4,126	3,017	10,177	10,910
Cost of revenue
Total cost of revenue	$ 2,621	$ 1,408	$ 6,662	$ 4,100

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (69,442)	$ (40,890)	$ (72,092)	$ (106,275)
Other comprehensive income (loss):
Foreign currency translation adjustment	(526)	(22)	(531)	14
Unrealized loss on short-term investments, net of tax	0	0	0	(23)
Other comprehensive (loss) income	(526)	(22)	(531)	(9)
Comprehensive loss	$ (69,968)	$ (40,912)	$ (72,623)	$ (106,284)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)		Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Temporary equity, beginning balance (in shares) at Jan. 31, 2020	[1]	160,583,203
Temporary equity, beginning balance at Jan. 31, 2020		$ 520,241,000
Temporary equity, ending balance (in shares) at Apr. 30, 2020	[1]	160,583,203
Temporary equity, ending balance at Apr. 30, 2020		$ 520,241,000
Beginning balance (in shares) at Jan. 31, 2020	[1]		11,918,418
Beginning balance at Jan. 31, 2020		(462,021,000)	$ 1,000	$ 20,331,000	$ 37,000	$ (482,390,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of vested stock options (in shares)	[1]		1,071,203
Issuance of common stock upon exercise of vested stock options		436,000		436,000
Vesting of early exercised stock options		10,000		10,000
Stock-based compensation		910,000		910,000
Net loss		(30,098,000)				(30,098,000)
Other comprehensive income (loss)		(56,000)			(56,000)
Ending balance (in shares) at Apr. 30, 2020	[1]		12,989,621
Ending balance at Apr. 30, 2020		$ (490,819,000)	$ 1,000	21,687,000	(19,000)	(512,488,000)
Temporary equity, beginning balance (in shares) at Jan. 31, 2020	[1]	160,583,203
Temporary equity, beginning balance at Jan. 31, 2020		$ 520,241,000
Temporary equity, ending balance (in shares) at Oct. 31, 2020	[1]	182,934,257
Temporary equity, ending balance at Oct. 31, 2020		$ 615,755,000
Beginning balance (in shares) at Jan. 31, 2020	[1]		11,918,418
Beginning balance at Jan. 31, 2020		(462,021,000)	$ 1,000	20,331,000	37,000	(482,390,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Foreign currency translation adjustment		14,000
Net loss		(106,275,000)
Other comprehensive income (loss)		(9,000)
Ending balance (in shares) at Oct. 31, 2020	[1]		15,854,300
Ending balance at Oct. 31, 2020		$ (531,017,000)	$ 2,000	57,618,000	28,000	(588,665,000)
Temporary equity, beginning balance (in shares) at Apr. 30, 2020	[1]	160,583,203
Temporary equity, beginning balance at Apr. 30, 2020		$ 520,241,000
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs (in shares)	[1]	21,783,334
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs		$ 92,433,000
Beneficial conversion feature in connection with Series H-1 redeemable preferred stock		(58,625,000)
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock		$ 58,625,000
Temporary equity, ending balance (in shares) at Jul. 31, 2020	[1]	182,366,537
Temporary equity, ending balance at Jul. 31, 2020		$ 612,674,000
Beginning balance (in shares) at Apr. 30, 2020	[1]		12,989,621
Beginning balance at Apr. 30, 2020		(490,819,000)	$ 1,000	21,687,000	(19,000)	(512,488,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse recapitalization		31,390,000		31,390,000
Beneficial conversion feature in connection with Series H-1 redeemable preferred stock		58,625,000		58,625,000
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock		58,625,000		58,625,000
Issuance of common stock upon exercise of vested stock options (in shares)	[1]		1,523,641
Issuance of common stock upon exercise of vested stock options		1,095,000		1,095,000
Issuance of common stock related to early exercise of stock options (in shares)	[1]		66,440
Vesting of early exercised stock options		1,000		1,000
Stock-based compensation		1,190,000		1,190,000
Net loss		(35,287,000)				(35,287,000)
Other comprehensive income (loss)		69,000			69,000
Ending balance (in shares) at Jul. 31, 2020	[1]		14,579,702
Ending balance at Jul. 31, 2020		$ (492,361,000)	$ 1,000	55,363,000	50,000	(547,775,000)
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs (in shares)	[1]	567,720
Issuance of redeemable convertible preferred stock and common warrants, net of issuance costs		$ 3,081,000
Beneficial conversion feature in connection with Series H-1 redeemable preferred stock		1,752,000
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock		$ 1,752,000
Temporary equity, ending balance (in shares) at Oct. 31, 2020	[1]	182,934,257
Temporary equity, ending balance at Oct. 31, 2020		$ 615,755,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse recapitalization		155,000		155,000
Beneficial conversion feature Series H-1 preferred warrants		1,752,000		1,752,000
Accretion of beneficial conversion feature in connection with Series H-1 redeemable preferred stock		(1,752,000)		(1,752,000)
Issuance of common stock upon exercise of vested stock options (in shares)	[1]		1,240,498
Issuance of common stock upon exercise of vested stock options		890,000	$ 1,000	889,000
Issuance of common stock related to early exercise of stock options (in shares)	[1]		34,100
Vesting of early exercised stock options		4,000		4,000
Stock-based compensation		1,207,000		1,207,000
Foreign currency translation adjustment		(22,000)			(22,000)
Net loss		(40,890,000)
Other comprehensive income (loss)		(22,000)
Ending balance (in shares) at Oct. 31, 2020	[1]		15,854,300
Ending balance at Oct. 31, 2020		$ (531,017,000)	$ 2,000	57,618,000	28,000	(588,665,000)
Temporary equity, beginning balance (in shares) at Jan. 31, 2021	[1]	182,934,257
Temporary equity, beginning balance at Jan. 31, 2021		$ 615,697,000
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend (in shares)	[1]	(182,934,257)
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend		$ (615,697,000)
Temporary equity, ending balance (in shares) at Apr. 30, 2021	[1]	0
Temporary equity, ending balance at Apr. 30, 2021		$ 0
Beginning balance (in shares) at Jan. 31, 2021	[1]		22,961,032
Beginning balance at Jan. 31, 2021		(616,521,000)	$ 2,000	62,736,000	155,000	(679,414,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend (in shares)	[1]		194,060,336
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend		615,697,000	$ 20,000	615,677,000
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse recapitalization		66,606,000		66,606,000
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)	[1]		60,746,989
Issuance of common stock upon the reverse recapitalization, net of issuance costs		200,466,000	$ 6,000	200,460,000
Issuance of common stock upon exercise of warrants (in shares)	[1]		9,766,774
Issuance of common stock upon exercise of warrants		225,376,000	$ 1,000	225,375,000
Contingent earnout liability recognized upon the closing of the reverse recapitalization		(828,180,000)		(828,180,000)
Issuance of earnout shares upon triggering events, net of tax withholding (in shares)	[1]		17,539,657
Issuance of earnout shares upon triggering events, net of tax withholding		488,305,000	$ 2,000	488,303,000
Reclassification of remaining contingent earnout liability upon triggering event		242,640,000		242,640,000
Vesting of early exercised stock options		78,000		78,000
Repurchase of early exercised common stock (in shares)	[1]		(1,588)
Stock-based compensation		7,577,000		7,577,000
Net loss		82,289,000				82,289,000
Other comprehensive income (loss)		7,000			7,000
Ending balance (in shares) at Apr. 30, 2021	[1]		305,073,200
Ending balance at Apr. 30, 2021		$ 484,340,000	$ 31,000	1,081,272,000	162,000	(597,125,000)
Temporary equity, beginning balance (in shares) at Jan. 31, 2021	[1]	182,934,257
Temporary equity, beginning balance at Jan. 31, 2021		$ 615,697,000
Temporary equity, ending balance (in shares) at Oct. 31, 2021	[1]	0
Temporary equity, ending balance at Oct. 31, 2021		$ 0
Beginning balance (in shares) at Jan. 31, 2021	[1]		22,961,032
Beginning balance at Jan. 31, 2021		$ (616,521,000)	$ 2,000	62,736,000	155,000	(679,414,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of vested stock options (in shares)		4,666,083
Foreign currency translation adjustment		$ (531,000)
Net loss		(72,092,000)
Other comprehensive income (loss)		(531,000)
Ending balance (in shares) at Oct. 31, 2021	[1]		330,987,173
Ending balance at Oct. 31, 2021		$ 585,399,000	$ 33,000	1,337,247,000	(376,000)	(751,505,000)
Temporary equity, beginning balance (in shares) at Apr. 30, 2021	[1]	0
Temporary equity, beginning balance at Apr. 30, 2021		$ 0
Temporary equity, ending balance (in shares) at Jul. 31, 2021	[1]	0
Temporary equity, ending balance at Jul. 31, 2021		$ 0
Beginning balance (in shares) at Apr. 30, 2021	[1]		305,073,200
Beginning balance at Apr. 30, 2021		484,340,000	$ 31,000	1,081,272,000	162,000	(597,125,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)	[1]		652,901
Issuance of common stock upon exercise of warrants (in shares)	[1]		4,378,568
Issuance of common stock upon exercise of warrants		113,608,000		113,608,000
Issuance of earnout shares upon triggering events, net of tax withholding (in shares)	[1]		8,773,596
Issuance of earnout shares upon triggering events, net of tax withholding		(8,080,000)	$ 1,000	(8,081,000)
Issuance of common stock upon exercise of vested stock options (in shares)	[1]		3,292,219
Issuance of common stock upon exercise of vested stock options		1,761,000		1,761,000
Vesting of early exercised stock options		40,000		40,000
Stock-based compensation		28,293,000		28,293,000
Net loss		(84,938,000)				(84,938,000)
Other comprehensive income (loss)		(12,000)
Ending balance (in shares) at Jul. 31, 2021	[1]		322,170,484
Ending balance at Jul. 31, 2021		$ 535,012,000	$ 32,000	1,216,893,000	150,000	(682,063,000)
Temporary equity, ending balance (in shares) at Oct. 31, 2021	[1]	0
Temporary equity, ending balance at Oct. 31, 2021		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, net of tax withholding (in shares)	[1]		1,741,713
Issuance of common stock under stock plans, net of tax withholding		976,000		976,000
Issuance of common stock upon exercise of warrants (in shares)	[1]		1,379,800
Issuance of common stock upon exercise of warrants		1,264,000		1,264,000
Issuance of common stock in connection with acquisitions (in shares)	[1]		5,695,176
Issuance of common stock in connection with acquisitions		102,058,000	$ 1,000	102,057,000
Vesting of early exercised stock options		35,000		35,000
Stock-based compensation		16,022,000		16,022,000
Foreign currency translation adjustment		(526,000)
Net loss		(69,442,000)
Other comprehensive income (loss)		(526,000)			(526,000)
Ending balance (in shares) at Oct. 31, 2021	[1]		330,987,173
Ending balance at Oct. 31, 2021		$ 585,399,000	$ 33,000	$ 1,337,247,000	$ (376,000)	$ (751,505,000)
[1]	The shares of the Company’s common and redeemable convertible preferred stock prior to the Merger (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.9966 established in the Merger as described in Note 3.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) (Parenthetical)	Feb. 26, 2021
Recapitalization exchange ratio	0.9966
Switchback
Recapitalization exchange ratio	0.9966

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Cash flows from operating activities
Net loss	$ (72,092)	$ (106,275)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	10,158	7,463
Non-cash operating lease cost	3,066	2,865
Stock-based compensation	51,893	3,308
Amortization of deferred contract acquisition costs	1,291	858
Deferred tax benefit	(370)	0
Change in fair value of contingent earnout liability	(84,420)	0
Transaction costs expensed	7,031	0
Other	2,203	1,043
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	(26,579)	10,053
Inventories	3,498	(5,975)
Prepaid expenses and other assets	(18,879)	(8,388)
Operating lease liabilities	(2,193)	(2,431)
Accounts payable	10,633	(2,397)
Accrued and other liabilities	16,110	1,569
Deferred revenue	29,715	9,085
Net cash used in operating activities	(109,083)	(70,921)
Cash flows from investing activities
Purchases of property and equipment	(12,064)	(8,913)
Maturities of investments	0	47,014
Cash paid for acquisitions, net of cash acquired	(205,329)	0
Net cash (used in) provided by investing activities	(217,393)	38,101
Cash flows from financing activities
Proceeds from issuance of redeemable convertible preferred stock	0	95,514
Proceeds from issuance of common stock warrants	0	31,545
Proceeds from the exercise of warrants	118,845	0
Merger and PIPE financing	511,646	0
Payment of deferred transaction costs	0	(513)
Payments of transaction costs related to Merger	(32,468)	0
Payment of tax withholding obligations on settlement of earnout shares	(20,895)	0
Repayment of borrowings	(36,051)	0
Proceeds from exercises of vested and unvested stock options	4,214	2,201
Change in driver funds and amounts due to customers	1,933	0
Net cash provided by financing activities	547,224	128,747
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(748)	13
Net increase in cash, cash equivalents, and restricted cash	220,000	95,940
Cash, cash equivalents, and restricted cash at beginning of period	145,891	73,153
Cash, cash equivalents, and restricted cash at end of period	365,891	169,093
Supplementary cash flow information
Cash paid for interest	346	2,120
Cash paid for taxes	119	145
Supplementary cash flow information on noncash investing and financing activities
Accretion of beneficial conversion feature of redeemable convertible preferred stock	0	60,377
Right-of-use assets obtained in exchange for lease liabilities	4,737	14,212
Deferred transaction costs not yet paid	0	3,385
Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities	1,939	914
Vesting of early exercised stock options	0	15
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization	615,697	0
Reclassification of Legacy ChargePoint redeemable convertible preferred stock warrant liability upon the reverse capitalization	66,606	0
Contingent earnout liability recognized upon the closing of the reverse recapitalization	828,180	0
Reclassification of remaining contingent earnout liability upon triggering event	242,640	0
Issuance of common stock in connection with acquisitions	102,057	0
Redeemable convertible preferred stock warrant liability
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	(9,237)	18,301
Private placement warrant liability
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities	$ (30,911)	$ 0

Description of Business and Bas

Description of Business and Basis of Presentation	9 Months Ended
	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	Description of Business and Basis of Presentation ChargePoint Holdings, Inc. (“ChargePoint” or the “Company,” “it,” “its”) designs, develops and markets networked electric vehicle (“EV”) charging system infrastructure (“Networked Charging Systems”) and cloud-based services which enable consumers the ability to locate, reserve and authenticate Networked Charging Systems, and to transact EV charging sessions on those systems (“Cloud” or “Cloud Services”). As part of ChargePoint’s Networked Charging Systems, subscriptions and other offerings, it provides an open platform that integrates with system hardware from ChargePoint and other manufacturers, connecting systems over an intelligent network that provides real-time information about charging sessions and full control, support and management of the Networked Charging Systems. This network also provides multiple web-based portals for charging system owners, fleet managers, drivers and utilities. In addition, the Company offers a range of extended parts and labor warranty (“Assure”) that includes proactive monitoring, fast response times, expert advice and robust reporting. The Company’s ChargePoint as a Service (“CPaaS”) program bundles use of ChargePoint owned and operated systems with Cloud Services, Assure and other benefits into one subscription. The Company’s fiscal year ends on January 31. References to fiscal year 2021 relate to the fiscal year ended January 31, 2021 and to fiscal year 2022 refer to the fiscal year ending January 31, 2022. Basis of Presentation The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting. The Company’s condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended January 31, 2021, and the related notes included in the Company’s registration statement on Form S-1 filed with the SEC on October 14, 2021, which provides a more complete discussion of the Company’s accounting policies and certain other information. The information as of January 31, 2021, included on the condensed consolidated balance sheets was derived from the Company’s audited consolidated financial statements. The condensed consolidated financial statements were prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company’s financial position as of October 31, 2021, and the results of operations for the three and nine months ended October 31, 2021 and 2020, and cash flows for the nine months ended October 31, 2021 and 2020. The results of operations for the three and nine months ended October 31, 2021, are not necessarily indicative of the results that may be expected for the year ending January 31, 2022. The Company’s condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its product offerings, raising capital and recruiting personnel. The Company’s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved at the levels or in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial efforts, or to pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company’s stockholders. The Company has incurred net operating losses and negative cash flows from operations in every year since inception and expects this to continue for the foreseeable future. As of October 31, 2021, the Company had an accumulated deficit of $751.5 million. The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock, exercise proceeds from options and warrants, borrowings under loan facilities, customer payments and proceeds from the Reverse Recapitalization (as defined below). The Company had cash, cash equivalents and restricted cash of $365.9 million as of October 31, 2021. As of December 15, 2021, the date on which these condensed consolidated financial statements were available to be issued, the Company believes that its cash on hand, together with cash generated from sales to customers, will satisfy its working capital and capital requirements for at least the next twelve months. The Company’s assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties. The Company’s actual results could vary as a result of, and its near- and long-term future capital requirements will depend on, many factors, including its growth rate, subscription renewal activity, the timing and extent of spending to support its acquisitions, infrastructure and research and development efforts, the expansion of sales and marketing activities, the timing of new introductions of products or features, the continuing market adoption of its Networked Charging Systems and Cloud Services platform, and the overall market acceptance of EVs. The Company has and may in the future enter into arrangements to acquire or invest in complementary businesses, services, and technologies, including intellectual property rights. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may be required to seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors, including market penetration, the introduction of new products, and potential acquisitions of related businesses or technology. If additional financing is required from outside sources, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results and financial condition would be adversely affected. On February 26, 2021 (“Closing Date”), Switchback Energy Acquisition Corporation (“Switchback”) consummated the previously announced transactions pursuant to which Lightning Merger Sub Inc., a wholly-owned subsidiary of Switchback incorporated in the State of Delaware (“Lightning Merger Sub”), merged with ChargePoint, Inc., a Delaware corporation (“Legacy ChargePoint”); Legacy ChargePoint survived as a wholly-owned subsidiary of Switchback (“such transaction, the “Merger,” and, collectively with the other transactions described in the Merger Agreement (as defined below), the “Reverse Recapitalization”). Further as a result of the Merger, Switchback was renamed “ChargePoint Holdings, Inc.” Please refer to Note 3 “Reverse Recapitalization and Business Combinations” for further details of the Merger.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Other than policies noted below, there have been no significant changes to the significant accounting policies disclosed in Note 2 of the audited consolidated financial statements as of January 31, 2021 and 2020 and for the years ended January 31, 2021, 2020, and 2019. Common Stock Warrant Liabilities The Company assumed 10,470,562 publicly-traded warrants (“Public Warrants”) and 6,521,568 private placement warrants issued to NGP Switchback, LLC, the sponsor of Switchback (“Private Placement Warrants” and, together with the Public Warrants, the “Common Stock Warrants”) upon the Merger, all of which were issued in connection with Switchback’s initial public offering and subsequent overallotment (other than 1,000,000 Private Placement Warrants which were issued in connection with the closing of the Merger) and entitle the holder to purchase one share of the Company’s Common Stock, par value $0.0001 (“Common Stock”), at an exercise price of $11.50 per share. During the nine months ended October 31, 2021, 10,226,081 Public Warrants and 4,349,342 Private Placement Warrants were exercised and the remaining 244,481 Public Warrants outstanding as of July 6, 2021, were redeemed for cash. The Public Warrants, prior to their redemption, were publicly traded and were exercisable for cash unless certain conditions occurred , such as the redemption by the Company under certain conditions, at which time the warrants could be cashlessly exercised, or the Company’s failure to have an effective registration statement related to the shares issuable upon exercise. The Private Placement Warrants are not redeemable for cash so long as they are held by the initial purchasers or their permitted transferees but may be redeemable for Common Stock if certain other conditions are met. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Pu blic Warrants. The Company evaluated the Common Stock Warrants and concluded that they do not meet the criteria to be classified within stockholders’ equity. The agreement governing the Common Stock Warrants includes a provision (“Replacement of Securities Upon Reorganization”), the application of which could result in a different settlement value for the Common Stock Warrants depending on their holder. Because the holder of an instrument is not an input into the pricing of a fixed-for-fixed option on the Company’s ordinary shares, the Private Placement Warrants are not considered to be “indexed to the Company’s own stock.” In addition, the provision provides that in the event of a tender or exchange offer accepted by holders of more than 50% of the outstanding shares of the Company’s ordinary shares, all holders of the Common Stock Warrants (both the Public Warrants and the Private Placement Warrants) would be entitled to receive cash for all of their Common Stock Warrants. Specifically, in the event of a qualifying cash tender offer (which could be outside of the Company’s control), all Common Stock Warrant holders would be entitled to cash, while only certain of the holders of the Company’s ordinary shares may be entitled to cash. These provisions preclude the Company from classifying the Common Stock Warrants in stockholders’ equity. As the Common Stock Warrants meet the definition of a derivative, the Company recorded these warrants as liabilities on the consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statements of operations and comprehensive loss at each reporting date. Contingent Earnout Liability In connection with the Reverse Recapitalization and pursuant to the Merger Agreement and Plan of Merger dated as of September 23, 2020, by and among the Company, Lightning Merger Sub Inc., and Switchback (“Merger Agreement”), eligible ChargePoint equity holders were entitled to receive as additional merger consideration shares of the Company’s Common Stock upon the Company achieving certain Earnout Triggering Events (as described in the Merger Agreement and Note 9). In accordance with ASC 815-40, the earnout shares were not indexed to the Common Stock and therefore were accounted for as a liability at the Reverse Recapitalization date and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statements of operations. The estimated fair value of the contingent consideration was determined using a Monte Carlo simulation using a distribution of potential outcomes on a monthly basis over the Earnout Period (as defined in Note 9) prioritizing the most reliable information available. The assumptions utilized in the calculation were based on the achievement of certain stock price milestones, including the current Company Common Stock price, expected volatility, risk-free rate, expected term and dividend rate. Until its settlement, the contingent earnout liability was categorized as a Level 3 fair value measurement (see Fair Value of Financial Instruments accounting policy as described above) because the Company estimated projections during the Earnout Period utilizing unobservable inputs. Contingent earnout payments involve certain assumptions requiring significant judgment and actual results can differ from assumed and estimated amounts. Use of Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and Common Stock warrants, including Common Stock Warrants as a result of the Merger, contingent earnout liability, valuation of acquired goodwill and intangible assets, the value of Common Stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks. At times cash deposit balances may be in excess of federal insurance limits. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition. Concentration of credit risk with respect to trade accounts receivable is considered to be limited due to the diversity of the Company’s customer base and geographic sales areas. As of October 31, 2021, and January 31, 2021, one customer individually accounted for 12% and 16% of accounts receivable, net, respectively. For the nine months ended October 31, 2021 and 2020, there were no customers that represented 10% or more of total revenue. The Company’s revenue is concentrated in the infrastructure needed for charging EVs, an industry which is highly competitive and rapidly changing. Significant technological changes within the industry or customer requirements, or the emergence of competitive products with new capabilities or technologies, could adversely affect the Company’s business, operating results and financial condition. Impact of COVID-19 In March 2020, the World Health Organization characterized COVID-19 as a pandemic. The impact of COVID-19, including changes in consumer and business behavior, pandemic fears and market downturns, and restrictions on business and individual activities, has created significant volatility in the global economy and led to reduced economic activity. The spread of COVID-19 has disrupted ChargePoint’s supply chain and heightened its freight and logistic costs, and has similarly disrupted manufacturing, delivery and overall supply chain of vehicle manufacturers and suppliers, which has led to fluctuations in EV sales around the world. As a result of the COVID-19 pandemic, ChargePoint has modified its business practices (including reducing employee travel, recommending that all non-essential personnel work from home and cancelling or reducing physical participation in sales activities, meetings, events and conferences), implemented additional safety protocols for essential workers, and implemented temporary cost cutting measures in order to reduce its operating costs. The Company may take further actions as may be required by government authorities or that it determines are in the best interests of its employees, customers, suppliers, vendors and business partners. While the ultimate duration and extent of the COVID-19 pandemic depends on current and future developments that cannot be accurately predicted, such as the extent and effectiveness of containment actions and vaccinations, it has already had an adverse effect on the global economy, and the ultimate full societal and economic impact of the COVID-19 pandemic remains unknown. The effect of the COVID-19 pandemic can also vary over time and across the geographies in which ChargePoint operates. For example, variations in work-from-home policies can cause fluctuations in ChargePoint’s revenues, and the Company believes that since people are not yet fully returning to work office locations, it has not yet seen the full return of commercial customer demand for its products. The conditions caused by the COVID-19 pandemic, such as more permanent work-from-home policies, are likely to continue affecting the rate of global infrastructure spending, and thus to continue to adversely impact ChargePoint’s commercial business and its overall gross margins as the Company’s commercial business presently contributes higher margins than its residential and fleet businesses. Further, the COVID-19 pandemic could continue to heighten supply chain pricing and logistics expenses, further adversely impacting ChargePoint’s gross margins, and could adversely affect demand for ChargePoint’s platforms, lengthen its product development and sales cycles, reduce the value, renewal rate or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from new customers, cause some of its paying customers to go out of business and limit the ability of its direct sales force to travel to customers and potential customers, all of which could adversely affect the Company’s business, results of operations and financial condition. Segment Reporting The Company operates as one operating segment because its Chief Executive Officer, as the Company’s chief operating decision maker, reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance. Fair Value of Financial Instruments Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value: • (Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; • (Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and • (Level 3) — Inputs that are unobservable for the asset or liability. The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material non-financial assets valued on a non-recurring basis that resulted in an impairment in any period presented. The carrying values of the Company’s cash equivalents, accounts receivable, net, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments. Remaining Performance Obligations Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and non-cancellable contracted amounts that will be invoiced and recognized as revenue in future periods. The Company’s Assure, Cloud and CPaaS subscription terms typically range from one Deferred Revenue Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of Cloud and Assure services not yet rendered as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a customer-by-customer basis. Current deferred revenue represents deferred revenue that will be recognized within twelve months, and non-current is deferred revenue that will be recognized beyond that twelve-month period. Total deferred revenue was $121.2 million and $89.8 million as of October 31, 2021 and January 31, 2021, respectively. The Company recognized $9.2 million and $7.5 million of revenue during the three months ended October 31, 2021 and October 31, 2020, and $31.8 million and $24.9 million of revenue during the nine months ended October 31, 2021 and October 31, 2020, respectively, that was included in the deferred revenue balance at the beginning of the period. Business Combinations The Company accounts for its acquisitions under ASC 805, Business Combinations . The Company allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired, based on their estimated fair values. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain identifiable assets include, but are not limited to, expected long-term market growth, future expected cost of revenue and operating expenses, and appropriate discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition costs, such as legal and consulting fees, are expensed as incurred. During the measurement period, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the consolidated statement of operations. The acquired intangible assets and goodwill are subject to impairment review at least annually on December 31. See Note 3 for additional information regarding the Company’s acquisitions. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes (“ASC 740”). Deferred tax assets are recognized for deductible temporary differences and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the financial reporting and tax bases of assets and liabilities. Deferred tax assets and liabilities are measured by applying enacted statutory tax rates applicable to the future years in which deferred tax assets or liabilities are expected to be settled or realized. Valuation allowances, if management deems them necessary, are established to reduce deferred tax assets to the amount that more likely than not will be realized and primarily relate to the ability to utilize losses in various tax jurisdictions. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be “more likely than not” to be sustained upon examination by taxing authorities. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax position liabilities for any of the reporting periods presented. Accounting Pronouncements The Company can adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as non-public business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as non-public business entities, as indicated below. Based on the Company’s public float as of July 31, 2021, it will become a large accelerated filer, and lose emerging growth company status, as of January 31, 2022. As of January 31, 2022, the Company will be required to adopt new or revised accounting standards when they are applicable to public companies that are not emerging growth companies. Recently Issued Accounting Standards In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and has since released various amendments including ASU No. 2019-04. The guidance modifies the measurement of expected credit losses on certain financial instruments. The Company will become a large accelerated filer effective January 31, 2022, at which point the Company will follow the timeline for adoption of new accounting pronouncements for public companies. As a result, the Company will adopt ASU 2016-13 for the January 31, 2022 annual period, with a modified retrospective application to all outstanding instruments and a cumulative effect adjustment recorded to opening retained earnings as of February 1, 2021, and is currently assessing the impact the guidance will have on its condensed consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis step-up in goodwill obtained in a transaction that is not a business combination. The guidance will be effective for annual reporting periods beginning after December 15, 2020, including interim periods therein. As a result, the Company will adopt ASU 2019-12 for the January 31, 2022 annual period and is currently assessing the impact the guidance will have on its condensed consolidated financial statements but does not expect a material impact. In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2020. As a result, the Company will adopt ASU 2020-06 for the January 31, 2022 annual period and is currently assessing the impact the guidance will have on its condensed consolidated financial statements. Recently Issued Accounting Standards Adopted In October 2021, the FASB issued ASU No. 2021-08, “ Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ” (“ASU 2021-08”), which requires entities to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers . The guidance will be effective for annual reporting periods beginning after December 15, 2022, including interim periods therein. Early adoption is permitted, including in an interim period for which the financial statements have not been issued. If early adopting in an interim period, the Company is required to apply the amendments to all prior business combinations that have occurred since the beginning of the fiscal year that includes the interim period of application. As a result, the Company adopted ASU 2021-08 effective as of October 31, 2021, retroactively applying the new guidance for all business combinations that occurred since February 1, 2021. The adoption of ASU 2021-08 did not have a material impact on the Company’s condensed consolidated financial statements.

Reverse Recapitalization & Busi

Reverse Recapitalization & Business Combinations	9 Months Ended
	Oct. 31, 2021
Reverse Recapitalization [Abstract]
Reverse Recapitalization & Business Combinations	Reverse Recapitalization and Business Combinations Reverse Recapitalization On February 26, 2021, Lightning Merger Sub, a wholly-owned subsidiary of Switchback, merged with Legacy ChargePoint, with Legacy ChargePoint surviving as a wholly-owned subsidiary of Switchback. As a result of the Merger, Switchback was renamed “ChargePoint Holdings, Inc.” Immediately prior to the closing of the Merger: • all 22,427,306 shares of Legacy ChargePoint’s outstanding Series H-1 redeemable convertible preferred stock were converted into an equivalent number of shares of Legacy ChargePoint common stock on a one-to-one basis and an additional 1,026,084 shares of Common Stock were issued to settle the accumulated dividend to the Series H-1 redeemable convertible preferred stockholders of $21.1 million; • all 160,925,957 shares of Legacy ChargePoint’s outstanding Series H, Series G, Series F, Series E, and Series D redeemable convertible preferred stock were converted into an equivalent number of shares of Legacy ChargePoint common stock on a one-to-one basis; • all 45,376 shares of Legacy ChargePoint’s outstanding Series C redeemable convertible preferred stock were converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:73.4403 basis; • all 130,590 shares of Legacy ChargePoint’s outstanding Series B redeemable convertible preferred stock were converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:42.9220 basis; and • all 29,126 shares of Legacy ChargePoint’s outstanding Series A redeemable convertible preferred stock were converted into an equivalent number of shares of Legacy ChargePoint common stock on a 1:48.2529 basis. At the Merger, eligible ChargePoint equity holders received or had the right to receive shares of Common Stock at a deemed value of $10.00 per share after giving effect to the exchange ratio of 0.9966 as defined in the Merger Agreement (“Exchange Ratio”). Accordingly, immediately following the consummation of the Merger, Legacy ChargePoint common stock exchanged into 217,021,368 shares of Common Stock, 68,896,516 shares were reserved for the issuance of Common Stock upon the potential future exercise of Legacy ChargePoint stock options and warrants that were exchanged into ChargePoint stock options and warrants, and 27,000,000 shares of Common Stock were reserved for the potential future issuance of the earnout shares. In connection with the execution of the Merger Agreement, Switchback entered into separate subscription agreements (each a “Subscription Agreement”) with a number of investors (each a “New PIPE Investor”), pursuant to which the New PIPE Investors agreed to purchase, and Switchback agreed to sell to the New PIPE Investors, an aggregate of 22,500,000 shares of Common Stock (“PIPE Shares”), for a purchase price of $10.00 per share and an aggregate purchase price of $225.0 million, in a private placement pursuant to the subscription agreements (“PIPE Financing”). The PIPE Financing closed simultaneously with the consummation of the Merger. Pursuant to the terms of a letter agreement the initial Switchback stockholders entered into in connection with the execution of the Merger Agreement (“Founders Stock Letter”), the initial stockholders surrendered 984,706 of Switchback Class B common stock shares purchased by NGP Switchback, LLC, a Delaware limited liability company (“Sponsor”) prior to the Switchback Public Offering on May 16, 2019 ( “Founder Shares”) for no consideration, whereupon such Founder Shares were immediately cancelled. Additionally, 900,000 Founder Shares, which were previously subjected to potential forfeiture until the closing volume weighted average price per share of the Company’s Common Stock achieved $12.00 for any ten trading days within any twenty consecutive trading day period during the five-year period following the Closing (“Founder Earn Back Triggering Event” and such Founder Shares the “Founder Earn Back Shares”), met the Founder Earn Back Triggering Event on March 12, 2021. At the Closing, the Sponsor exercised its right to convert a portion of the working capital loans made by the Sponsor to Switchback into an additional 1,000,000 Private Placement Warrants at a price of $1.50 per warrant in satisfaction of $1.5 million principal amount of such loans. The number of shares of Common Stock issued immediately following the consummation of the Merger was as follows: Shares Common stock of Switchback, outstanding prior to Merger 39,264,704 Less redemption of Switchback shares (33,009) Less surrender of Switchback Founder Shares (984,706) Common stock of Switchback 38,246,989 Shares issued in PIPE 22,500,000 Merger and PIPE financing shares (1) 60,746,989 Legacy ChargePoint shares (2) 217,021,368 Total shares of common stock immediately after Merger 277,768,357 _______________ (1) This includes 900,000 contingently forfeitable Founder Earn Back Shares pending the occurrence of the Founder Earn Back Triggering Event, which was met on March 12, 2021 (2) The number of Legacy ChargePoint shares was determined by converting the 217,761,738 shares of Legacy ChargePoint common stock outstanding immediately prior to the closing of the Merger using the Exchange Ratio of 0.9966. All fractional shares were rounded down. The Merger is accounted for as a reverse recapitalization under U.S. GAAP. This determination is primarily based on Legacy ChargePoint stockholders comprising a relative majority of the voting power of ChargePoint and having the ability to nominate the members of the Board of Directors, Legacy ChargePoint’s operations prior to the acquisition comprising the only ongoing operations of ChargePoint, and Legacy ChargePoint’s senior management comprising a majority of the senior management of ChargePoint. Under this method of accounting, Switchback is treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of ChargePoint represent a continuation of the financial statements of Legacy ChargePoint with the Merger being treated as the equivalent of ChargePoint issuing stock for the net assets of Switchback, accompanied by a recapitalization. The net assets of Switchback are stated at historical costs, with no goodwill or other intangible assets recorded. Operations prior to the Merger are presented as those of ChargePoint. All periods prior to the Merger have been retrospectively adjusted using the Exchange Ratio for the equivalent number of shares outstanding immediately after the Merger to effect the reverse recapitalization. Additionally, upon the consummation of the Merger, the Company gave effect to the issu ance of 60,746,989 shares o f Common Stock for the previously issued Switchback common stock and PIPE Shares that were outstanding at the Closing Date. In connection with the Merger, the Company raised $511.6 million of proceeds including the contribution of $286.6 million of cash held in Switchback’s trust account from its initial public offering, net of redemptions of Switchback public stockholders of $0.3 million, and $225.0 million of cash in connection with the PIPE financing. The Company incurred $36.5 million of transaction costs, consisting of banking, legal, and other professional fees, of which $29.5 million was recorded as a reduction to additional paid-in capital of proceeds and the remaining $7.0 million was expensed in the condensed consolidated statements of operations. Acquisitions The Company acquired two companies in its third fiscal quarter ended October 31, 2021. The allocation of the purchase price consideration for each acquisition is preliminary and subject to revision as additional information about the fair value of assets and liabilities becomes available. Additional information that existed as of the respective acquisition dates, but at the time was unknown, may become known to the Company during the remainder of the remeasurement period, which is a period not to exceed 12 months from the respective acquisition dates. As of October 31, 2021, the Company continued to review the detailed valuation analyses to derive the fair value of assets acquired and liabilities assumed from the acquisitions, including developed technology, customer relationships and the related tax impacts; therefore, the purchase price allocations are based on provisional estimates and subject to continuing management analysis. Acquisition of ViriCiti B.V. On August 11, 2021, the Company acquired all of the outstanding shares of ViriCiti B.V. (“ViriCiti”) for $79.4 million in cash, subject to adjustments, as well as up to $7.7 million of additional earnout consideration contingent on meeting certain revenue targets through January 31, 2023 (“ViriCiti Earnout”). ViriCiti is a Netherlands-based provider of electrification solutions for eBus and commercial fleets with offices in the Netherlands and the United States. The acquisition is expected to enhance ChargePoint’s fleet solutions portfolio of hardware, software and services by integrating information sources to optimize electric fleet operations. The acquisition of ViriCiti was considered a business combination and was accounted for under the acquisition method of accounting. The total purchase price was allocated to the net tangible and intangible assets acquired and liabilities assumed based on their respective fair values on the acquisition date and the excess was recorded as goodwill. The ViriCiti Earnout liability was valued using a Monte Carlo simulation valuation model using a distribution of potential outcomes over the earnout period based on the most reliable information available. Assumptions used in the valuation are a risk-free interest rate of 0.8%, volatility of 34% and the currently forecasted applicable revenue. The liability will be remeasured to fair value based upon the attainment against the revenue targets and changes in the fair value of earnout liabilities will be presented in the condensed consolidated statements of operations. The Company incurred acquisition-related expenses of $2.2 million, which were recorded as general and administrative expenses in the consolidated statement of operations. The following table summarized the preliminary purchase consideration (in thousands): Amount Cash consideration $ 79,415 ViriCiti Earnout consideration (1) 3,908 Total purchase consideration $ 83,323 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates. The preliminary assets acquired and liabilities assumed in connection with the acquisition were recorded at their fair value at the acquisition date as follows (in thousands): Amount Cash and cash equivalents $ 623 Accounts receivable, net 1,248 Other assets 3,215 Customer relationships 17,683 Developed technology 6,558 Goodwill 62,703 Deferred tax liabilities, net (3,378) Other liabilities (5,329) Total acquired assets and assumed liabilities $ 83,323 The results of operations of ViriCiti are included in the accompanying consolidated statements of operations from the date of acquisition. ViriCiti’s results of operations since the date of acquisition were not material to the Company’s consolidated results of operations. Acquisition of has•to•be gmbh On October 6, 2021, the Company acquired all of the outstanding shares of has•to•be gmbh (“has.to.be” or “HTB”) for approximately $232.2 million, consisting of $130.1 million in cash, subject to further adjustments based on certain working capital positions and $102.1 million in the form of 5,695,176 shares of ChargePoint Common Stock valued at $17.92 per share on the acquisition date. Of these shares, 885,692, valued at $15.9 million, are held in escrow to cover indemnity claims the Company may make within eighteen months from the closing date. HTB is an Austria-based e-mobility provider with a European charging software platform. The acquisition is intended to expand the Company’s market share in Europe. The acquisition of HTB was considered a business combination and was accounted for under the acquisition method of accounting. The total purchase price was allocated to the net tangible and intangible assets acquired and liabilities assumed based on their respective fair values on the acquisition date, and the excess was recorded as goodwill. The Company incurred acquisition-related expenses of $2.6 million, which were recorded as general and administrative expenses in the consolidated statement of operations. The following table summarized the preliminary purchase consideration (in thousands): Amount Cash consideration $ 130,134 Common Stock consideration 102,057 Total purchase consideration $ 232,191 The preliminary assets acquired and liabilities assumed in connection with the acquisition were recorded at their fair value at the acquisition date as follows (in thousands): Amount Cash and cash equivalents $ 3,663 Accounts receivable, net 3,764 Other assets 4,259 Customer relationships 103,072 Technology 16,621 Goodwill 136,638 Other liabilities (10,509) Deferred tax liability, net (25,317) Total acquired assets and assumed liabilities $ 232,191 Supplemental Pro Forma Information The following unaudited pro forma financial information summarizes the combined results of operations for the Company and HTB as if the companies were combined as of February 1, 2020 (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 Revenue $ 66,571 $ 38,176 $ 168,736 $ 109,251 Net Loss $ (70,559) $ (44,807) $ (80,708) $ (119,334) The unaudited pro forma information above include the following adjustments to net loss in the pro forma periods presented (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 An increase in amortization expense $ (2,402) $ (3,407) $ (9,889) $ (9,694) An (increase) decrease in expenses related to transaction 2,556 — 2,556 (2,556) An (increase) decrease in tax provision (38) 852 1,833 3,062 Overall (increase) decrease in net loss 116 (2,555) (5,500) (9,188) ChargePoint net loss (69,442) (40,890) (72,092) (106,275) HTB net loss (1,233) (1,362) (3,116) (3,871) Pro forma net loss $ (70,559) $ (44,807) $ (80,708) $ (119,334) The unaudited supplemental pro forma information presented for HTB is for illustrative purposes only and is not necessarily indicative of results of operations that would have been achieved had the acquisitions taken place on the date indicated, or of the Company’s future consolidated results of operations. The supplemental pro forma information presented above has been derived from the Company’s historical consolidated financial statements and from the historical unaudited accounting records of HTB. Pro forma results of operations for ViriCiti have not been presented because the effect of the acquisition was not material to the condensed consolidated statements of operations. Goodwill and Intangible Assets The following table summarizes the changes in carrying amounts of goodwill (in thousands): Balance as of January 31, 2021 $ 1,215 Goodwill acquired with ViriCiti acquisition 62,703 Goodwill acquired with HTB acquisition 136,638 Foreign exchange fluctuations 125 Balance as of October 31, 2021 $ 200,681 Goodwill from these acquisitions represents the future economic benefits arising from other assets that could not be individually identified and separately recognized, such as the acquired assembled workforce. Goodwill is not deductible for tax purposes . The following table presents the details of intangible assets (amounts in thousands, useful lives in years): October 31, 2021 Cost (1) Accumulated Amortization (1) Net (1) Useful Life ViriCiti Customer relationships $ 17,683 $ (390) $ 17,293 10 Developed technology 6,558 (241) 6,317 6 HTB Customer relationships 103,179 (703) 102,476 10 Developed technology 16,638 (185) 16,453 6 $ 144,058 $ (1,519) $ 142,539 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates. The fair value assigned to customer relationships was determined using the income approach and the fair value assigned to developed technology was determined using relief from royalty rate method, based on analysis of royalty rate licensing data of market participants. Amortization expense for customer relationships and developed technology is shown as sales and marketing and cost of revenue, respectively, in the consolidated statement of operations. The acquired intangible assets and goodwill are subject to impairment review at least annually on December 31. Acquisition-related intangible assets included in the above table are finite-lived and are carried at cost less accumulated amortization. Intangible assets are being amortized on a straight-line basis over their estimated lives, which approximates the pattern in which the economic benefits of the intangible assets are expected to be realized. Amortization expense was $1.5 million for the three and nine months ended October 31, 2021. There was no amortization expense for the three and nine months ended October 31, 2020. The Company recorded net deferred tax liabilities of $3.4 million on August 11, 2021 and $25.3 million on October 6, 2021, associated with the acquisitions of ViriCiti and HTB, respectively. Deferred tax assets and liabilities are netted and presented in the condensed consolidated balance sheets.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows: Fair Value Measured as of October 31, 2021 Level 1 Level 2 Level 3 Total (in thousands) Assets Money market funds $ 254,714 $ — $ — $ 254,714 Total financial assets $ 254,714 $ — $ — $ 254,714 Liabilities Common stock warrant liabilities (Private Placement) $ — $ — $ 29,282 $ 29,282 Contingent earnout liability recognized upon acquisition of ViriCiti (ViriCiti Earnout) — — 3,856 3,856 Total financial liabilities $ — $ — $ 33,138 $ 33,138 Fair Value Measured as of January 31, 2021 Level 1 Level 2 Level 3 Total (in thousands) Assets Money market funds $ 109,703 $ — $ — $ 109,703 Total financial assets $ 109,703 $ — $ — $ 109,703 Liabilities Redeemable convertible preferred stock warrant liability $ — $ — $ 75,843 $ 75,843 Total financial liabilities $ — $ — $ 75,843 $ 75,843 The money market funds were classified as cash and cash equivalents on the condensed consolidated balance sheets. The aggregate fair value of the Company’s money market funds approximated amortized cost and, as such, there were no unrealized gains or losses on money market funds as of October 31, 2021 and January 31, 2021. Realized gains and losses, net of tax, were not material for any of the periods presented. As of October 31, 2021 and January 31, 2021, the Company had no investments with a contractual maturity of greater than one year. The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments: Redeemable convertible preferred stock warrant liability Private placement warrant liability Earnout liability and ViriCiti Earnout liability (in thousands) Fair value as of January 31, 2021 $ (75,843) $ — $ — Private placement warrant liability acquired as part of the merger — (127,888) — Contingent earnout liability recognized upon the closing of the reverse recapitalization — — (828,180) Change in fair value included in other income (expense), net 9,237 46,835 84,420 Reclassification of warrants to stockholders’ equity (deficit) due to exercise — 51,771 — Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization 66,606 — — Issuance of earnout shares upon triggering events — — 501,120 Reclassification of remaining contingent earnout liability upon triggering event — — 242,640 Contingent earnout liability recognized upon the acquisition of ViriCiti (ViriCiti Earnout) — — (3,856) Fair value as of October 31, 2021 $ — $ (29,282) $ (3,856) Redeemable convertible preferred stock warrant liability, Private Placement Liability and the Earnout Liability

Composition of Certain Financia

Composition of Certain Financial Statement Items	9 Months Ended
	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Composition of Certain Financial Statement Items	Composition of Certain Financial Statement Items Inventories Inventories consisted of the following: October 31, January 31, (in thousands) Raw materials $ 7,489 $ 13,029 Work-in-progress 199 68 Finished goods 22,205 20,495 Total Inventories $ 29,893 $ 33,592 Property and equipment, net Property and equipment, net consisted of the following: October 31, January 31, (in thousands) Furniture and fixtures $ 893 $ 1,594 Computers and software 5,786 5,384 Machinery and equipment 14,776 10,605 Tooling 10,506 7,705 Leasehold improvements 10,644 9,398 Owned and operated systems 21,236 17,703 Construction in progress 3,460 2,462 67,301 54,851 Less: Accumulated depreciation (32,575) (24,863) Total Property and Equipment, Net $ 34,726 $ 29,988 Depreciation expense for the three months ended October 31, 2021 and 2020 was $3.1 million and $2.8 million, respectively. Depreciation expense for the nine months ended October 31, 2021 and 2020 was $8.6 million and $7.5 million, respectively. Accrued and other current liabilities Accrued and other current liabilities consisted of the following: October 31, January 31, (in thousands) Accrued expenses $ 28,673 $ 18,404 Refundable customer deposits 8,286 6,482 Taxes payable 9,760 5,213 Payroll and related expenses 12,917 7,547 Warranty accruals 3,766 3,000 Operating lease liabilities, current 3,665 2,393 Other liabilities 9,406 4,123 Total Accrued and Other Current Liabilities $ 76,473 $ 47,162 Revenue Revenue consisted of the following: Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 (in thousands) (in thousands) United States $ 54,561 $ 29,681 $ 139,321 $ 92,319 Rest of World 10,473 6,684 22,344 11,779 Total revenue $ 65,034 $ 36,365 $ 161,665 $ 104,098

Debt

Debt	9 Months Ended
	Oct. 31, 2021
Debt Disclosure [Abstract]
Debt	Debt In July 2018, the Company entered into a term loan facility with certain lenders (“2018 Loan”) with a borrowing capacity of $45.0 million to finance working capital and repay all outstanding amounts owed under previous loans. The Company borrowed $35.0 million, with issuance costs of $1.1 million and net proceeds of $33.9 million. The 2018 Loan was secured by substantially all of the Company’s assets, contained customary affirmative and negative covenants, and required the Company to maintain minimum cash balances and attain certain customer billing targets. The 2018 Loan had a five-year maturity and interest was calculated at LIBOR plus 6.55%. The 2018 Loan agreement was amended on March 20, 2019, to extend the interest only monthly payments through June 30, 2021, to be followed by equal monthly payments of principal and interest. As of January 31, 2021, the Company was in compliance with all financial and non-financial debt covenants. Transaction costs upon entering into the 2018 Loan were recorded as debt discount and were amortized over the term of the 2018 Loan. There was no interest expense incurred during the three months ending October 31, 2021; the interest expense incurred during the three months ended October 31, 2020 was $0.8 million. Total interest expense incurred during the nine months ended October 31, 2021 and 2020 was $1.5 million and $2.4 million, respectively. In March 2021, the Company repaid the entire loan balance of $35.0 million plus accrued interest and prepayment fees of $1.2 million.

Commitment and Contingencies

Commitment and Contingencies	9 Months Ended
	Oct. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Commitments Open purchase commitments are for the purchase of goods and services related to, but not limited to, manufacturing, facilities and professional services under non-cancellable contracts. As of October 31, 2021, the Company had open purchase commitments for goods and services of $157.8 million, all of which are expected to be received by June 30, 2024. Legal Proceedings The Company may be involved in various lawsuits, claims, and proceedings, including intellectual property, commercial, securities, and employment matters that arise in the normal course of business. The Company accrues a liability when management believes information available prior to the issuance of the condensed consolidated financial statements indicates it is probable a loss has been incurred as of the date of the condensed consolidated financial statements and the amount of loss can be reasonably estimated. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Legal costs are expensed as incurred. The Company believes it has recorded adequate provisions for any such lawsuits, claims, and proceedings and, as of October 31, 2021, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in the condensed consolidated financial statements. Based on its experience, the Company believes that damage amounts claimed in these matters are not meaningful indicators of potential liability. Given the inherent uncertainties of litigation, the ultimate outcome of the ongoing matters described herein cannot be predicted with certainty. While litigation is inherently unpredictable, the Company believes it has valid defenses with respect to the legal matters pending against it. Nevertheless, the condensed consolidated financial statements could be materially adversely affected in a particular period by the resolution of one or more of these contingencies. Liabilities established to provide for contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved; and such changes are recorded in the accompanying condensed consolidated statements of operations during the period of the change and reflected in accrued and other current liabilities on the accompanying condensed consolidated balance sheets. Guarantees and Indemnifications The Company has service level commitments to certain of its customers warranting levels of uptime reliability and performance and permitting those customers to receive credits if the Company fails to meet those levels. To date, the Company has not incurred any material costs as a result of such commitments. The Company’s arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third-party’s intellectual property rights. Additionally, the Company may be required to indemnify for claims caused by its negligence or willful misconduct. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, the Company has not incurred any material costs as a result of such obligations and has not accrued any liabilities related to such obligations in the condensed consolidated financial statements. The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company also may be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. Leases The Company leases its office facilities under non-cancelable operating leases with various lease terms. The Company also leases certain office equipment under operating lease agreements. The following table presents future payments of lease liabilities under the Company's non-cancelable operating leases as of October 31, 2021 (in thousands): (in thousands) 2022 (remaining three months) $ 1,680 2023 6,388 2024 5,764 2025 5,328 2026 4,404 Thereafter 14,683 Total undiscounted operating lease payments 38,247 Less: imputed interest (10,799) Total operating lease liabilities 27,448 Less: current portion of operating lease liabilities (3,653) Operating lease liabilities, noncurrent $ 23,795

Common Stock

Common Stock	9 Months Ended
	Oct. 31, 2021
Equity [Abstract]
Common Stock	Common Stock On February 26, 2021, the Merger was consummated and the Company issued 60,746,989 shares for an aggregate purchase price of $200.5 million, net of issuance costs of $29.4 million. Immediately following the Merger, there were 277,768,357 shares of Common Stock outstanding with a par value of $0.0001. The holder of each share of Common Stock is entitled to one vote. The Company has retroactively adjusted the shares issued and outstanding prior to February 26, 2021, to give effect to the Exchange Ratio established in the Merger Agreement to determine the number of shares of Common Stock into which they were converted. Immediately prior to the Merger, 484,951,532 shares were authorized to issue at $0.0001 par value, with 299,771,284 shares designated as Common Stock and 185,180,248 shares of redeemable convertible preferred stock. Common Stock Reserved for Future Issuance Shares of Common Stock reserved for future issuance, on an as-if converted basis, were as follows: October 31, Stock options issued and outstanding 24,855,043 Restricted stock units outstanding 3,906,058 Common stock warrants outstanding 37,756,829 Shares available for grant under 2021 Equity Incentive Plan 36,436,447 Shares available for grant under 2021 ESPP 8,177,683 Total shares of Common Stock reserved 111,132,060 On February 26, 2021, upon the closing of the Merger (Note 3), all of the outstanding redeemable convertible preferred stock was converted to Common Stock pursuant to the conversion rate effective immediately prior to the Merger, and the remaining amount was reclassified to additional paid-in capital.

Stock Warrants and Earnouts

Stock Warrants and Earnouts	9 Months Ended
	Oct. 31, 2021
Equity [Abstract]
Stock Warrants and Earnouts	Stock Warrants and Earnout Redeemable Convertible Preferred Stock Warrants Warrants to purchase a total of 2,358,528 shares of Series B, D and E redeemable convertible preferred stock were initially recognized as a liability recorded at fair value upon issuance and were subject to remeasurement to fair value at each balance sheet date. As part of the Merger, Legacy ChargePoint redeemable convertible preferred stock was converted into Legacy ChargePoint common stock pursuant to the conversion rate effective immediately prior to the Merger while all related Legacy ChargePoint preferred stock warrants were converted into warrants exercisable for shares of Common Stock with terms consistent with the Legacy ChargePoint preferred stock warrants except for the number of shares exercisable therefor and the exercise price, each of which was adjusted using the Exchange Ratio. At that time, the redeemable convertible preferred stock warrant liability was remeasured and reclassified to additional paid-in capital. The liability associated with these warrants was subject to remeasurement at each balance sheet date using the Level 3 fair value inputs. See Note 4 for further details. The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows: February 26, 2021 January 31, Expected volatility 84.3 % 80.5 % Risk-free interest rate 0.0 % 0.1 % Dividend rate 0.0 % 0.0 % Expected term (years) 0.0 1.4 Common Stock Warrants In addition to the warrants to purchase 2,358,528 shares of Legacy ChargePoint preferred stock described above, Legacy ChargePoint had outstanding warrants to purchase 36,402,503 shares of Legacy ChargePoint common stock (collectively, “Legacy Warrants”), which now represent warrants to purchase Common Stock. During the three months ended October 31, 2021, 1,491,243 Legacy Warrants were exercised resulting in the issuance of 1,379,036 shares of Common Stock. During the nine months ended October 31, 2021, 3,176,428 Legacy Warrants were net exercised resulting in the issuance of 2,866,560 shares of Common Stock. During the three and nine months ended October 31, 2021, proceeds received for the exercise of Legacy Warrants were $1.2 million. As of October 31, 2021, there were 35,584,603 Legacy Warrants outstanding which are classified as equity. Private Placement Warrants The Private Placement Warrants were initially recognized as a liability on February 26, 2021, at a fair value of $127.9 million and the Private Placement Warrant liability was remeasured to fair value as of any respective exercise dates and as of October 31, 2021. The Company recorded a gain (loss) of $(2.4) million and $30.9 million for the three and nine months ended October 31, 2021, respectively, classified within change in fair value of warrant liabilities in the condensed consolidated statements of operations. As of October 31, 2021, there were 2,172,226 Private Placement Warrants outstanding. The Private Placement Warrants were valued using the following assumptions under the BLM that assumes optimal exercise of the Company’s redemption option at the earliest possible date: October 31, February 26, Market price of public stock $24.78 $30.83 Exercise price $11.50 $11.50 Expected term (years) 4.3 5.0 Volatility 70.5 % 73.5 % Risk-free interest rate 1.0 % 0.8 % Dividend rate 0.0 % 0.0 % Public Warrants The Public Warrants may only be exercised for a whole number of shares. The Public Warrants became exercisable 30 days after the completion of the Merger. The Public Warrants were initially recognized as a liability on February 26, 2021 at a fair value of $153.7 million and the public warrant liability was remeasured to fair value based upon the market price as warrants were exercised. On June 4, 2021 the Company issued a redemption notice pursuant to which all but 244,481 Public Warrants were exercised by the Public Warrant holders. At the conclusion of the redemption notice period on July 6, 2021, the Company redeemed the remaining 244,481 Public Warrants outstanding for $0.01 per warrant. The Company recognized no gain or loss for the three months ended October 31, 2021, and recognized a loss of $15.9 million for the nine months ended October 31, 2021, classified within change in fair value of warrant liabilities in the condensed consolidated statements of operations. During the nine months ended October 31, 2021, proceeds received for the exercise of Public Warrants were $117.6 million. As of October 31, 2021, no Public Warrants remained outstanding. Activity of warrants is set forth below: Legacy Warrants (1) Private Placement Warrants Public Warrants Total Common Stock Warrants (1) Outstanding as of January 31, 2021 38,761,031 — — 38,761,031 Common Stock Warrants as Part of the Merger — 6,521,568 10,470,562 16,992,130 Warrants Exercised (3,176,428) (4,349,342) (10,226,081) (17,751,851) Warrants Redeemed — — (244,481) (244,481) Outstanding as of October 31, 2021 35,584,603 2,172,226 — 37,756,829 _______________ (1) The shares (and the warrants' exercise prices) subject to the Company's Legacy Warrants were restated to reflect the Exchange Ratio of approximately 0.9966 established in the Merger Agreement as discussed in Note 3. Contingent Earnout Liability During the five year period starting at the closing of the Merger (“Earnout Period”), eligible former equity holders of Legacy ChargePoint were eligible to receive up to 27,000,000 additional shares of Common Stock (“Earnout Shares”) in three equal tranches if the Earnout Triggering Events (as described in the Merger Agreement) were fully satisfied. The three Earnout Triggering Events were the dates on which the closing volume weighted-average price (“VWAP”) per share of common stock quoted on the NYSE (or the exchange on which the shares of the Company’s Common Stock are then listed) is greater or equal to $15.00, $20.00 and $30.00, respectively, for any ten trading days within any 20 consecutive trading day period within the Earnout Period. Upon the closing of the Merger, the contingent obligation to issue Earnout Shares was accounted for as a liability because the Earnout Triggering Events that determine the number of Earnout Shares required to be issued include events that are not solely indexed to the Common Stock of ChargePoint. The estimated fair value of the total Earnout Shares at the closing of the Merger on February 26, 2021, was $828.2 million based on a Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the Earnout Period using the most reliable information available. Assumptions used in the valuation are described below. March 12, February 26, Current stock price $27.84 $30.83 Expected volatility 72.00 % 71.60 % Risk-free interest rate 0.85 % 0.75 % Dividend rate 0.00 % 0.00 % Expected term (years) 4.96 5.00 The first two Earnout Triggering Events for up to 18,000,000 of the Earnout Shares occurred on March 12, 2021, and, after withholding some of these Earnout Shares to cover employee withholding tax obligations, 17,539,657 Earnout Shares were issued on March 19, 2021, and the estimated fair value of the earnout liability was remeasured to $743.7 million, including (i) $501.1 million related to the Earnout Shares issuable upon the occurrence of the Earnout Triggering Event associated with the $15.00 and $20.00 VWAP per share thresholds based on the Common Stock price as of March 12, 2021, and (ii) $242.6 million related to the estimated fair value of earnout liability related to the remaining 9,000,000 Earnout Shares issuable upon the occurrence of the Earnout Triggering Event associated with the $30.00 VWAP per share threshold based on a Monte Carlo simulation valuation model as of March 12, 2021, as described above. The change in fair value resulted in a gain of $84.4 million recognized in the condensed consolidated statement of operations for the three months ended April 30, 2021. Upon settlement of the first two tranches, the classification of the remaining 9,000,000 Earnout Shares of the third tranche was changed to equity on March 12, 2021, because the Earnout Shares became an instrument contingently issuable upon the occurrence of the Earnout Triggering Event into a fixed number of Common Shares that is not based on an observable market price or index other than the Company’s own stock price. The third and final Earnout Triggering Event for up to 9,000,000 of the Earnout Shares associated with the $30.00 VWAP per share threshold occurred on June 29, 2021, and, after the withholding of some of these Earnout Shares to cover employee withholding tax obligations, 8,773,596 Earnout Shares were issued on July 1, 2021. No further Earnout Shares remained contingently issuable as of October 31, 2021.

Equity Plans and Stock-based Co

Equity Plans and Stock-based Compensation	9 Months Ended
	Oct. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock Option Plan and Stock-based Compensation	Equity Plans and Stock-based Compensation On February 25, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan (“2021 EIP”) and the 2021 Employee Stock Purchase Plan (“2021 ESPP”). As of October 31, 2021, 36,436,447 and 8,177,683 shares of Common Stock were available under the 2021 EIP and 2021 ESPP, respectively. 2021 Employee Stock Purchase Plan The 2021 ESPP permits participants to purchase shares of the Company’s Common Stock, up to the IRS allowable limit, through contributions (in the form of payroll deductions or otherwise to the extent permitted by the administrator) of up to 15% of their eligible compensation. The 2021 ESPP provides for consecutive, overlapping 24-month offering periods, subject to certain rollover and reset mechanisms as defined in the ESPP. Participants are permitted to purchase shares of the Company’s Common Stock at the end of each 6-month purchase period at 85% of the lower of the fair market value of the Company’s Common Stock on the first trading day of an offering period or on the last trading date in each purchase period. A participant may purchase a maximum of 10,000 shares of the Company’s Common Stock during a purchase period. Participants may end their participation at any time during an offering and will be paid their accrued contributions that have not yet been used to purchase shares. Participation ends automatically upon termination of employment with the Company. The initial offering period is from October 1, 2021 through September 9, 2023. Further, on the first day of each March during the term of the 2021 ESPP, commencing on March 1, 2021 and ending on (and including) March 1, 2040, the aggregate number of shares of Common Stock that may be issued under the 2021 ESPP shall automatically increase by a number equal to the lesser of (i) one percent (1%) of the total number of shares of Common Stock issued and outstanding on the last day of the preceding month, (ii) 5,400,000 shares (subject to standard anti-dilution adjustments), or (iii) a number of shares determined by the Company’s Board of Directors. 2021 Equity Incentive Plan Under the 2021 EIP, the Company can grant stock options, stock appreciation rights, restricted stock, restricted stock units (“RSU”) and certain other awards which are settled in the form of shares of Common Stock issued under this 2021 EIP. On the first day of each March, beginning on March 1, 2021 and continuing through March 1, 2030, the 2021 EIP reserve will automatically increase by a number equal to the lesser of (a) 5% of the total number of shares actually issued and outstanding on the last day of the preceding month and (b) a number of shares determined by the Company’s Board of Directors. 2017 Plan and 2007 Plan No further awards will be granted under Legacy ChargePoint’s 2017 Stock Plan (“2017 Plan”) and 21,412,248 shares of Common Stock remain reserved for outstanding awards issued under the 2017 Plan as of October 31, 2021. Additionally, no other awards can be granted under Legacy ChargePoint’s 2007 Stock Incentive Plan (“2007 Plan”) and 3,442,795 shares of Common Stock remained reserved for outstanding awards issued under the 2007 Plan as of October 31, 2021. The Company’s stock option awards activity is set forth below: Number of Stock Option Awards Weighted Average Exercise Price Weighted Average Remaining Contractual term (in years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2021 30,166,792 $ 0.71 7.3 $ 1,064,539 Options exercised (4,666,083) $ 0.59 Options forfeited (624,618) $ 0.74 Options expired (21,048) $ 53.26 Outstanding as of October 31, 2021 24,855,043 $ 0.69 6.8 $ 598,912 Options vested and expected to vest as of October 31, 2021 24,314,890 $ 0.68 6.7 $ 585,934 Exercisable as of October 31, 2021 16,523,251 $ 0.66 6.2 $ 398,582 The options outstanding as of October 31, 2021, include the June 2020 grant of a stock option under the 2017 Plan to the Company’s Chief Executive Officer to purchase a total of 1.5 million shares of Common Stock (“CEO Award”) originally subject to both service and performance-based vesting conditions. No stock-based compensation expense had been recorded prior to the Merger as the CEO Awards were improbable of vesting before and after two modifications in each of September 2020 and December 2020, because the performance-based vesting condition was contingent upon the closing of the Merger. Accordingly, the Company commenced recognition of stock-based compensation expense for the CEO Award following the Merger in February 2021 when the only remaining vesting condition was service-based. As of October 31, 2021, the total unrecognized compensation expense related to the unvested portion of the CEO Award was $31.7 million, which is expected to be recognized over a period of 2.25 years. The Company’s RSU activity is set forth below: Number of Shares Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2021 — $ — RSU granted 5,042,559 $ 26.94 RSU vested (1,019,817) $ 27.36 RSU forfeited (116,684) $ 27.17 Outstanding as of October 31, 2021 3,906,058 $ 26.82 As of October 31, 2021, unrecognized stock-based compensation expense for employee equity plans was $125.2 million and is expected to be recognized over a weighted-average period of 2.6 years The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s condensed consolidated statements of operations: Three Months Ended Nine Months Ended 2021 2020 2021 2020 (in thousands) (in thousands) Cost of revenue $ 885 $ 29 $ 3,073 $ 93 Research and development 5,840 448 20,198 1,205 Sales and marketing 2,251 333 7,018 988 General and administrative 7,046 398 21,604 1,022 Total stock-based compensation expense $ 16,022 $ 1,208 $ 51,893 $ 3,308

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe income tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate as adjusted for discrete items arising in that quarter. The effective income tax rate was nil for the three and nine months ended October 31, 2021 and 2020. The effective tax rate differs from the U.S. statutory rate primarily due to the full valuation allowances on the Company’s net domestic deferred tax assets as it is more likely than not that all of the deferred tax assets will not be realized.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Oct. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Daimler AG and its affiliated entities (“Daimler”) are investors in the Company and one of its employees is a member of the Company’s Board of Directors. The following revenue transactions took place between the Company and Daimler during the periods presented: Three Months Ended Nine Months Ended 2021 2020 2021 2020 (in thousands) (in thousands) Daimler $ 1,290 $ 953 $ 4,696 $ 2,529 Revenue from related parties $ 1,290 $ 953 $ 4,696 $ 2,529 Related party accounts receivable as of October 31, 2021 and January 31, 2021 from Daimler was $2.3 million and $1.2 million, respectively.

Basic and Diluted Net Loss per

Basic and Diluted Net Loss per Share	9 Months Ended
	Oct. 31, 2021
Earnings Per Share [Abstract]
Basic and Diluted Net Loss per Share	Basic and Diluted Net Loss per Share The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and nine months ended October 31, 2021 and 2020: Three Months Ended Nine Months Ended 2021 2020 2021 2020 (in thousands, except share and per share data) (in thousands, except share and per share data) Numerator: Net income (loss) $ (69,442) $ (40,890) $ (72,092) $ (106,275) Adjust: Accretion of beneficial conversion feature of redeemable convertible preferred stock — (1,752) — (60,377) Adjust: Cumulative dividends on redeemable convertible preferred stock — (3,960) (4,292) (3,960) Adjust: Deemed dividends attributable to vested option holders — — (51,855) — Adjust: Deemed dividends attributable to common stock warrant holders — — (110,635) — Net loss attributable to common stockholders - Basic (69,442) (46,602) (238,874) (170,612) Less: Gain attributable to earnout shares issued — — (84,420) — Less: Change in fair value of dilutive warrants — — (51,106) — Net loss attributable to common stockholders - Diluted $ (69,442) $ (46,602) $ (374,400) $ (170,612) Denominator: Weighted average common shares outstanding 325,223,132 15,102,625 286,272,045 13,550,552 Less: Weighted-average unvested restricted shares and shares subject to repurchase (188,212) (111,759) (246,562) — Weighted average shares outstanding - Basic 325,034,920 14,990,866 286,025,483 13,550,552 Add: Earnout Shares under the treasury stock method — — 4,948,794 — Add: Public and Private Placement Warrants under the treasury stock method — — 1,601,041 — Weighted average shares outstanding - Diluted 325,034,920 14,990,866 292,575,318 13,550,552 Net loss per share - Basic $ (0.21) $ (3.11) $ (0.84) $ (12.59) Net loss per share - Diluted $ (0.21) $ (3.11) $ (1.28) $ (12.59) As a result of the Merger, the Company has retroactively adjusted the weighted-average number of shares of Common Stock outstanding prior to the Closing Date by multiplying them by the Exchange Ratio of 0.9966 used to determine the number of shares of Common Stock into which they converted. The Common Stock issued as a result of the redeemable convertible preferred stock conversion on the Closing Date was included in the basic net loss per share calculation on a prospective basis. Redeemable convertible preferred stock and preferred stock warrants outstanding prior to the Merger Closing Date were excluded from the diluted net loss per share calculation for the nine-months period ended October 31, 2021, because including them would have had an antidilutive effect. The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows: October 31, October 31, Redeemable convertible preferred stock (on an as-converted basis) — 193,484,162 Options to purchase common stock 24,855,043 37,547,865 Restricted stock units 3,906,058 — Unvested early exercised common stock options 164,778 129,717 Common stock and preferred stock warrants 35,584,603 38,761,061 Employee stock purchase plan 942,335 — Total potentially dilutive common share equivalents 65,452,817 269,922,805

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting. The Company’s condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations.
Assumed Common Stock Warrant Liability	The agreement governing the Common Stock Warrants includes a provision (“Replacement of Securities Upon Reorganization”), the application of which could result in a different settlement value for the Common Stock Warrants depending on their holder. Because the holder of an instrument is not an input into the pricing of a fixed-for-fixed option on the Company’s ordinary shares, the Private Placement Warrants are not considered to be “indexed to the Company’s own stock.” In addition, the provision provides that in the event of a tender or exchange offer accepted by holders of more than 50% of the outstanding shares of the Company’s ordinary shares, all holders of the Common Stock Warrants (both the Public Warrants and the Private Placement Warrants) would be entitled to receive cash for all of their Common Stock Warrants. Specifically, in the event of a qualifying cash tender offer (which could be outside of the Company’s control), all Common Stock Warrant holders would be entitled to cash, while only certain of the holders of the Company’s ordinary shares may be entitled to cash. These provisions preclude the Company from classifying the Common Stock Warrants in stockholders’ equity. As the Common Stock Warrants meet the definition of a derivative, the Company recorded these warrants as liabilities on the consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statements of operations and comprehensive loss at each reporting date.
Contingent Earnout Liability	In connection with the Reverse Recapitalization and pursuant to the Merger Agreement and Plan of Merger dated as of September 23, 2020, by and among the Company, Lightning Merger Sub Inc., and Switchback (“Merger Agreement”), eligible ChargePoint equity holders were entitled to receive as additional merger consideration shares of the Company’s Common Stock upon the Company achieving certain Earnout Triggering Events (as described in the Merger Agreement and Note 9). In accordance with ASC 815-40, the earnout shares were not indexed to the Common Stock and therefore were accounted for as a liability at the Reverse Recapitalization date and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statements of operations. The estimated fair value of the contingent consideration was determined using a Monte Carlo simulation using a distribution of potential outcomes on a monthly basis over the Earnout Period (as defined in Note 9) prioritizing the most reliable information available. The assumptions utilized in the calculation were based on the achievement of certain stock price milestones, including the current Company Common Stock price, expected volatility, risk-free rate, expected term and dividend rate. Until its settlement, the contingent earnout liability was categorized as a Level 3 fair value measurement (see Fair Value of Financial Instruments accounting policy as described above) because the Company estimated projections during the Earnout Period utilizing unobservable inputs. Contingent earnout payments involve certain assumptions requiring significant judgment and actual results can differ from assumed and estimated amounts.
Use of Estimates	The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments and assumptions. Significant estimates include determining standalone selling price for performance obligations in contracts with customers, the estimated expected benefit period for deferred contract acquisition costs, allowances for doubtful accounts, inventory reserves, the useful lives of long-lived assets, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of redeemable convertible preferred stock warrants and Common Stock warrants, including Common Stock Warrants as a result of the Merger, contingent earnout liability, valuation of acquired goodwill and intangible assets, the value of Common Stock and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration of Credit Risk and Other Risks and Uncertainties	Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are held in domestic and foreign cash accounts with large, creditworthy financial institutions. The Company has not experienced any losses on its deposits of cash and cash equivalents through deposits with federally insured commercial banks. At times cash deposit balances may be in excess of federal insurance limits. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.
Segment Reporting	The Company operates as one operating segment because its Chief Executive Officer, as the Company’s chief operating decision maker, reviews its financial information on a consolidated basis for purposes of making decisions regarding allocating resources and assessing performance.
Fair Value of Financial Instruments	Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. Assets and liabilities measured at fair value are classified into the following categories based on the inputs used to measure fair value: • (Level 1) — Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; • (Level 2) — Inputs other than quoted prices in active markets that are observable for the asset or liability, either directly or indirectly; and • (Level 3) — Inputs that are unobservable for the asset or liability. The Company classifies financial instruments in Level 3 of the fair value hierarchy when there is reliance on at least one significant unobservable input to the valuation model. In addition to these unobservable inputs, the valuation models for Level 3 financial instruments typically also rely on a number of inputs that are readily observable, either directly or indirectly. The Company’s assessment of a particular input to the fair value measurement requires management to make judgments and consider factors specific to the asset or liability. The fair value hierarchy requires the use of observable market data when available in determining fair value. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each period. There were no transfers between levels during the periods presented. The Company had no material non-financial assets valued on a non-recurring basis that resulted in an impairment in any period presented. The carrying values of the Company’s cash equivalents, accounts receivable, net, accounts payable, and accrued and other current liabilities approximate fair value based on the highly liquid, short-term nature of these instruments.
Remaining Performance Obligations and Deferred Revenue	Remaining performance obligations represents the amount of contracted future revenue not yet recognized as the amounts relate to undelivered performance obligations, including both deferred revenue and non-cancellable contracted amounts that will be invoiced and recognized as revenue in future periods. Deferred revenue represents billings or payments received in advance of revenue recognition and is recognized in revenue upon transfer of control. Balances consist primarily of Cloud and Assure services not yet rendered as of the balance sheet date. Contract assets, which represent services provided or products transferred to customers in advance of the date the Company has a right to invoice, are netted against deferred revenue on a customer-by-customer basis. Current deferred revenue represents deferred revenue that will be recognized within twelve months, and
Business Combinations	The Company accounts for its acquisitions under ASC 805, Business Combinations . The Company allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired, based on their estimated fair values. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain identifiable assets include, but are not limited to, expected long-term market growth, future expected cost of revenue and operating expenses, and appropriate discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition costs, such as legal and consulting fees, are expensed as incurred. During the measurement period, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the consolidated statement of operations. The acquired intangible assets and goodwill are subject to impairment review at least annually on December 31. See Note 3 for additional information regarding the Company’s acquisitions.
Income Taxes	The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes (“ASC 740”). Deferred tax assets are recognized for deductible temporary differences and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the financial reporting and tax bases of assets and liabilities. Deferred tax assets and liabilities are measured by applying enacted statutory tax rates applicable to the future years in which deferred tax assets or liabilities are expected to be settled or realized. Valuation allowances, if management deems them necessary, are established to reduce deferred tax assets to the amount that more likely than not will be realized and primarily relate to the ability to utilize losses in various tax jurisdictions. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be “more likely than not” to be sustained upon examination by taxing authorities. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax position liabilities for any of the reporting periods presented.
Accounting Pronouncements	The Company can adopt new or revised accounting guidance as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”) either (1) within the same periods as those otherwise applicable to public business entities, or (2) within the same time periods as non-public business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as non-public business entities, as indicated below. Based on the Company’s public float as of July 31, 2021, it will become a large accelerated filer, and lose emerging growth company status, as of January 31, 2022. As of January 31, 2022, the Company will be required to adopt new or revised accounting standards when they are applicable to public companies that are not emerging growth companies. Recently Issued Accounting Standards In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and has since released various amendments including ASU No. 2019-04. The guidance modifies the measurement of expected credit losses on certain financial instruments. The Company will become a large accelerated filer effective January 31, 2022, at which point the Company will follow the timeline for adoption of new accounting pronouncements for public companies. As a result, the Company will adopt ASU 2016-13 for the January 31, 2022 annual period, with a modified retrospective application to all outstanding instruments and a cumulative effect adjustment recorded to opening retained earnings as of February 1, 2021, and is currently assessing the impact the guidance will have on its condensed consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis step-up in goodwill obtained in a transaction that is not a business combination. The guidance will be effective for annual reporting periods beginning after December 15, 2020, including interim periods therein. As a result, the Company will adopt ASU 2019-12 for the January 31, 2022 annual period and is currently assessing the impact the guidance will have on its condensed consolidated financial statements but does not expect a material impact. In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), which modifies and simplifies accounting for convertible instruments. The new guidance eliminates certain separation models that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance will be effective for annual reporting periods beginning after December 15, 2020. As a result, the Company will adopt ASU 2020-06 for the January 31, 2022 annual period and is currently assessing the impact the guidance will have on its condensed consolidated financial statements. Recently Issued Accounting Standards Adopted In October 2021, the FASB issued ASU No. 2021-08, “ Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ” (“ASU 2021-08”), which requires entities to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers . The guidance will be effective for annual reporting periods beginning after December 15, 2022, including interim periods therein. Early adoption is permitted, including in an interim period for which the financial statements have not been issued. If early adopting in an interim period, the Company is required to apply the amendments to all prior business combinations that have occurred since the beginning of the fiscal year that includes the interim period of application. As a result, the Company adopted ASU 2021-08 effective as of October 31, 2021, retroactively applying the new guidance for all business combinations that occurred since February 1, 2021. The adoption of ASU 2021-08 did not have a material impact on the Company’s condensed consolidated financial statements.

Reverse Recapitalization & Bu_2

Reverse Recapitalization & Business Combinations (Tables)	9 Months Ended
	Oct. 31, 2021
Reverse Recapitalization [Abstract]
Schedule of Reverse Recapitalization	The number of shares of Common Stock issued immediately following the consummation of the Merger was as follows: Shares Common stock of Switchback, outstanding prior to Merger 39,264,704 Less redemption of Switchback shares (33,009) Less surrender of Switchback Founder Shares (984,706) Common stock of Switchback 38,246,989 Shares issued in PIPE 22,500,000 Merger and PIPE financing shares (1) 60,746,989 Legacy ChargePoint shares (2) 217,021,368 Total shares of common stock immediately after Merger 277,768,357 _______________ (1) This includes 900,000 contingently forfeitable Founder Earn Back Shares pending the occurrence of the Founder Earn Back Triggering Event, which was met on March 12, 2021 (2) The number of Legacy ChargePoint shares was determined by converting the 217,761,738 shares of Legacy ChargePoint common stock outstanding immediately prior to the closing of the Merger using the Exchange Ratio of 0.9966. All fractional shares were rounded down.
Schedule of Business Acquisitions, by Acquisition	The following table summarized the preliminary purchase consideration (in thousands): Amount Cash consideration $ 79,415 ViriCiti Earnout consideration (1) 3,908 Total purchase consideration $ 83,323 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates. The following table summarized the preliminary purchase consideration (in thousands): Amount Cash consideration $ 130,134 Common Stock consideration 102,057 Total purchase consideration $ 232,191
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The preliminary assets acquired and liabilities assumed in connection with the acquisition were recorded at their fair value at the acquisition date as follows (in thousands): Amount Cash and cash equivalents $ 623 Accounts receivable, net 1,248 Other assets 3,215 Customer relationships 17,683 Developed technology 6,558 Goodwill 62,703 Deferred tax liabilities, net (3,378) Other liabilities (5,329) Total acquired assets and assumed liabilities $ 83,323 The preliminary assets acquired and liabilities assumed in connection with the acquisition were recorded at their fair value at the acquisition date as follows (in thousands): Amount Cash and cash equivalents $ 3,663 Accounts receivable, net 3,764 Other assets 4,259 Customer relationships 103,072 Technology 16,621 Goodwill 136,638 Other liabilities (10,509) Deferred tax liability, net (25,317) Total acquired assets and assumed liabilities $ 232,191
Business Acquisition, Pro Forma Information	The following unaudited pro forma financial information summarizes the combined results of operations for the Company and HTB as if the companies were combined as of February 1, 2020 (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 Revenue $ 66,571 $ 38,176 $ 168,736 $ 109,251 Net Loss $ (70,559) $ (44,807) $ (80,708) $ (119,334) The unaudited pro forma information above include the following adjustments to net loss in the pro forma periods presented (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 An increase in amortization expense $ (2,402) $ (3,407) $ (9,889) $ (9,694) An (increase) decrease in expenses related to transaction 2,556 — 2,556 (2,556) An (increase) decrease in tax provision (38) 852 1,833 3,062 Overall (increase) decrease in net loss 116 (2,555) (5,500) (9,188) ChargePoint net loss (69,442) (40,890) (72,092) (106,275) HTB net loss (1,233) (1,362) (3,116) (3,871) Pro forma net loss $ (70,559) $ (44,807) $ (80,708) $ (119,334)
Schedule of Goodwill	The following table summarizes the changes in carrying amounts of goodwill (in thousands): Balance as of January 31, 2021 $ 1,215 Goodwill acquired with ViriCiti acquisition 62,703 Goodwill acquired with HTB acquisition 136,638 Foreign exchange fluctuations 125 Balance as of October 31, 2021 $ 200,681
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	The following table presents the details of intangible assets (amounts in thousands, useful lives in years): October 31, 2021 Cost (1) Accumulated Amortization (1) Net (1) Useful Life ViriCiti Customer relationships $ 17,683 $ (390) $ 17,293 10 Developed technology 6,558 (241) 6,317 6 HTB Customer relationships 103,179 (703) 102,476 10 Developed technology 16,638 (185) 16,453 6 $ 144,058 $ (1,519) $ 142,539 _______________ (1) Values are translated into U.S. Dollars at period-end foreign exchange rates.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows: Fair Value Measured as of October 31, 2021 Level 1 Level 2 Level 3 Total (in thousands) Assets Money market funds $ 254,714 $ — $ — $ 254,714 Total financial assets $ 254,714 $ — $ — $ 254,714 Liabilities Common stock warrant liabilities (Private Placement) $ — $ — $ 29,282 $ 29,282 Contingent earnout liability recognized upon acquisition of ViriCiti (ViriCiti Earnout) — — 3,856 3,856 Total financial liabilities $ — $ — $ 33,138 $ 33,138 Fair Value Measured as of January 31, 2021 Level 1 Level 2 Level 3 Total (in thousands) Assets Money market funds $ 109,703 $ — $ — $ 109,703 Total financial assets $ 109,703 $ — $ — $ 109,703 Liabilities Redeemable convertible preferred stock warrant liability $ — $ — $ 75,843 $ 75,843 Total financial liabilities $ — $ — $ 75,843 $ 75,843
Summary of Changes in the Fair Value of the Company's Level 3 Financial Instruments	The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments: Redeemable convertible preferred stock warrant liability Private placement warrant liability Earnout liability and ViriCiti Earnout liability (in thousands) Fair value as of January 31, 2021 $ (75,843) $ — $ — Private placement warrant liability acquired as part of the merger — (127,888) — Contingent earnout liability recognized upon the closing of the reverse recapitalization — — (828,180) Change in fair value included in other income (expense), net 9,237 46,835 84,420 Reclassification of warrants to stockholders’ equity (deficit) due to exercise — 51,771 — Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization 66,606 — — Issuance of earnout shares upon triggering events — — 501,120 Reclassification of remaining contingent earnout liability upon triggering event — — 242,640 Contingent earnout liability recognized upon the acquisition of ViriCiti (ViriCiti Earnout) — — (3,856) Fair value as of October 31, 2021 $ — $ (29,282) $ (3,856)

Composition of Certain Financ_2

Composition of Certain Financial Statement Items (Tables)	9 Months Ended
	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Inventories	Inventories consisted of the following: October 31, January 31, (in thousands) Raw materials $ 7,489 $ 13,029 Work-in-progress 199 68 Finished goods 22,205 20,495 Total Inventories $ 29,893 $ 33,592
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following: October 31, January 31, (in thousands) Furniture and fixtures $ 893 $ 1,594 Computers and software 5,786 5,384 Machinery and equipment 14,776 10,605 Tooling 10,506 7,705 Leasehold improvements 10,644 9,398 Owned and operated systems 21,236 17,703 Construction in progress 3,460 2,462 67,301 54,851 Less: Accumulated depreciation (32,575) (24,863) Total Property and Equipment, Net $ 34,726 $ 29,988
Schedule of Accrued and Other Current Liabilities	Accrued and other current liabilities consisted of the following: October 31, January 31, (in thousands) Accrued expenses $ 28,673 $ 18,404 Refundable customer deposits 8,286 6,482 Taxes payable 9,760 5,213 Payroll and related expenses 12,917 7,547 Warranty accruals 3,766 3,000 Operating lease liabilities, current 3,665 2,393 Other liabilities 9,406 4,123 Total Accrued and Other Current Liabilities $ 76,473 $ 47,162
Schedule of Revenue	Revenue consisted of the following: Three Months Ended October 31, Nine Months Ended October 31, 2021 2020 2021 2020 (in thousands) (in thousands) United States $ 54,561 $ 29,681 $ 139,321 $ 92,319 Rest of World 10,473 6,684 22,344 11,779 Total revenue $ 65,034 $ 36,365 $ 161,665 $ 104,098

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	9 Months Ended
	Oct. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Lease Payments Under All Non-cancellable Operating Leases	The following table presents future payments of lease liabilities under the Company's non-cancelable operating leases as of October 31, 2021 (in thousands): (in thousands) 2022 (remaining three months) $ 1,680 2023 6,388 2024 5,764 2025 5,328 2026 4,404 Thereafter 14,683 Total undiscounted operating lease payments 38,247 Less: imputed interest (10,799) Total operating lease liabilities 27,448 Less: current portion of operating lease liabilities (3,653) Operating lease liabilities, noncurrent $ 23,795

Common Stock (Tables)

Common Stock (Tables)	9 Months Ended
	Oct. 31, 2021
Equity [Abstract]
Schedule of Common Stock Reserved for Future Issuance	Shares of Common Stock reserved for future issuance, on an as-if converted basis, were as follows: October 31, Stock options issued and outstanding 24,855,043 Restricted stock units outstanding 3,906,058 Common stock warrants outstanding 37,756,829 Shares available for grant under 2021 Equity Incentive Plan 36,436,447 Shares available for grant under 2021 ESPP 8,177,683 Total shares of Common Stock reserved 111,132,060

Stock Warrants and Earnouts (Ta

Stock Warrants and Earnouts (Tables)	9 Months Ended
	Oct. 31, 2021
Equity [Abstract]
Fair Value Measurement Inputs and Valuation Techniques	The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows: February 26, 2021 January 31, Expected volatility 84.3 % 80.5 % Risk-free interest rate 0.0 % 0.1 % Dividend rate 0.0 % 0.0 % Expected term (years) 0.0 1.4 The Private Placement Warrants were valued using the following assumptions under the BLM that assumes optimal exercise of the Company’s redemption option at the earliest possible date: October 31, February 26, Market price of public stock $24.78 $30.83 Exercise price $11.50 $11.50 Expected term (years) 4.3 5.0 Volatility 70.5 % 73.5 % Risk-free interest rate 1.0 % 0.8 % Dividend rate 0.0 % 0.0 % March 12, February 26, Current stock price $27.84 $30.83 Expected volatility 72.00 % 71.60 % Risk-free interest rate 0.85 % 0.75 % Dividend rate 0.00 % 0.00 % Expected term (years) 4.96 5.00
Schedule of Common Stock Warrants	Activity of warrants is set forth below: Legacy Warrants (1) Private Placement Warrants Public Warrants Total Common Stock Warrants (1) Outstanding as of January 31, 2021 38,761,031 — — 38,761,031 Common Stock Warrants as Part of the Merger — 6,521,568 10,470,562 16,992,130 Warrants Exercised (3,176,428) (4,349,342) (10,226,081) (17,751,851) Warrants Redeemed — — (244,481) (244,481) Outstanding as of October 31, 2021 35,584,603 2,172,226 — 37,756,829 _______________ (1) The shares (and the warrants' exercise prices) subject to the Company's Legacy Warrants were restated to reflect the Exchange Ratio of approximately 0.9966 established in the Merger Agreement as discussed in Note 3.

Equity Plans and Stock-based _2

Equity Plans and Stock-based Compensation (Tables)	9 Months Ended
	Oct. 31, 2021
Share-based Payment Arrangement [Abstract]
Share-based Payment Arrangement, Option, Activity	The Company’s stock option awards activity is set forth below: Number of Stock Option Awards Weighted Average Exercise Price Weighted Average Remaining Contractual term (in years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2021 30,166,792 $ 0.71 7.3 $ 1,064,539 Options exercised (4,666,083) $ 0.59 Options forfeited (624,618) $ 0.74 Options expired (21,048) $ 53.26 Outstanding as of October 31, 2021 24,855,043 $ 0.69 6.8 $ 598,912 Options vested and expected to vest as of October 31, 2021 24,314,890 $ 0.68 6.7 $ 585,934 Exercisable as of October 31, 2021 16,523,251 $ 0.66 6.2 $ 398,582
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity	The Company’s RSU activity is set forth below: Number of Shares Weighted Average Grant Date Fair Value per Share Outstanding as of January 31, 2021 — $ — RSU granted 5,042,559 $ 26.94 RSU vested (1,019,817) $ 27.36 RSU forfeited (116,684) $ 27.17 Outstanding as of October 31, 2021 3,906,058 $ 26.82
Schedule of Stock-based Compensation Expense	The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s condensed consolidated statements of operations: Three Months Ended Nine Months Ended 2021 2020 2021 2020 (in thousands) (in thousands) Cost of revenue $ 885 $ 29 $ 3,073 $ 93 Research and development 5,840 448 20,198 1,205 Sales and marketing 2,251 333 7,018 988 General and administrative 7,046 398 21,604 1,022 Total stock-based compensation expense $ 16,022 $ 1,208 $ 51,893 $ 3,308

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Oct. 31, 2021
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following revenue transactions took place between the Company and Daimler during the periods presented: Three Months Ended Nine Months Ended 2021 2020 2021 2020 (in thousands) (in thousands) Daimler $ 1,290 $ 953 $ 4,696 $ 2,529 Revenue from related parties $ 1,290 $ 953 $ 4,696 $ 2,529

Basic and Diluted Net Loss pe_2

Basic and Diluted Net Loss per Share (Tables)	9 Months Ended
	Oct. 31, 2021
Earnings Per Share [Abstract]
Schedule of Loss Per Share Attributable to Common Stockholders, Basic and Diluted	The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and nine months ended October 31, 2021 and 2020: Three Months Ended Nine Months Ended 2021 2020 2021 2020 (in thousands, except share and per share data) (in thousands, except share and per share data) Numerator: Net income (loss) $ (69,442) $ (40,890) $ (72,092) $ (106,275) Adjust: Accretion of beneficial conversion feature of redeemable convertible preferred stock — (1,752) — (60,377) Adjust: Cumulative dividends on redeemable convertible preferred stock — (3,960) (4,292) (3,960) Adjust: Deemed dividends attributable to vested option holders — — (51,855) — Adjust: Deemed dividends attributable to common stock warrant holders — — (110,635) — Net loss attributable to common stockholders - Basic (69,442) (46,602) (238,874) (170,612) Less: Gain attributable to earnout shares issued — — (84,420) — Less: Change in fair value of dilutive warrants — — (51,106) — Net loss attributable to common stockholders - Diluted $ (69,442) $ (46,602) $ (374,400) $ (170,612) Denominator: Weighted average common shares outstanding 325,223,132 15,102,625 286,272,045 13,550,552 Less: Weighted-average unvested restricted shares and shares subject to repurchase (188,212) (111,759) (246,562) — Weighted average shares outstanding - Basic 325,034,920 14,990,866 286,025,483 13,550,552 Add: Earnout Shares under the treasury stock method — — 4,948,794 — Add: Public and Private Placement Warrants under the treasury stock method — — 1,601,041 — Weighted average shares outstanding - Diluted 325,034,920 14,990,866 292,575,318 13,550,552 Net loss per share - Basic $ (0.21) $ (3.11) $ (0.84) $ (12.59) Net loss per share - Diluted $ (0.21) $ (3.11) $ (1.28) $ (12.59)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows: October 31, October 31, Redeemable convertible preferred stock (on an as-converted basis) — 193,484,162 Options to purchase common stock 24,855,043 37,547,865 Restricted stock units 3,906,058 — Unvested early exercised common stock options 164,778 129,717 Common stock and preferred stock warrants 35,584,603 38,761,061 Employee stock purchase plan 942,335 — Total potentially dilutive common share equivalents 65,452,817 269,922,805

Description of Business and B_2

Description of Business and Basis of Presentation (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021	Oct. 31, 2020	Jan. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ (751,505)	$ (679,414)
Cash, cash equivalents, and restricted cash	$ 365,891	$ 145,891	$ 169,093	$ 73,153

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Common Stock Warrant Liability (Details) - $ / shares	Jul. 06, 2021	Jun. 04, 2021	Oct. 31, 2021	Feb. 26, 2021	Feb. 25, 2021	Jan. 31, 2021
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)			37,756,829			38,761,031
Common stock, par value (USD per share)			$ 0.0001	$ 0.0001		$ 0.0001
Warrants exercised (in shares)			17,751,851
Warrants redeemed (in shares)			244,481
Public Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)			0		10,470,562	0
Warrants exercised (in shares)		244,481	10,226,081
Warrants redeemed (in shares)	244,481		244,481
Public Warrants | Common Class A | Switchback
Class of Warrant or Right [Line Items]
Common stock, par value (USD per share)				0.0001
Stock price of warrants (in dollars per share)				$ 11.50
Private Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)				1,000,000	6,521,568

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Concentration of Credit Risk (Details)	6 Months Ended	9 Months Ended
	Jul. 31, 2021	Oct. 31, 2021
Accounts Receivable | Customer Concentration Risk | Largest Customer
Concentration Risk [Line Items]
Concentration risk, percentage	16.00%	12.00%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Segment Reporting (Details)	9 Months Ended
	Oct. 31, 2021segment
Accounting Policies [Abstract]
Number of operating segments	1

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Remaining Performance Obligations (Details) $ in Millions	9 Months Ended
	Oct. 31, 2021USD ($)
Minimum
Deferred Revenue Arrangement [Line Items]
Subscription term (in years)	1 year
Maximum
Deferred Revenue Arrangement [Line Items]
Subscription term (in years)	5 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-11-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 132.8
Revenue expected to be recognized from remaining performance obligations (as percent)	47.00%
Revenue expected to be recognized from remaining performance obligations (in months)	12 months

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Deferred Revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020	Jan. 31, 2021
Accounting Policies [Abstract]
Contract with customer liability	$ 121.2		$ 121.2		$ 89.8
Contract with customer liability, revenue recognized	$ 9.2	$ 7.5	$ 31.8	$ 24.9

Reverse Recapitalization & Bu_3

Reverse Recapitalization & Business Combinations - Narrative (Details)	Oct. 06, 2021USD ($)$ / sharesshares	Aug. 11, 2021USD ($)	Jun. 29, 2021shares	Mar. 12, 2021shares	Feb. 26, 2021USD ($)day$ / sharesshares	Oct. 31, 2021USD ($)	Oct. 31, 2020USD ($)	Oct. 31, 2021USD ($)	Oct. 31, 2020USD ($)	Jan. 31, 2021USD ($)
Schedule Of Reverse Recapitalization [Line Items]
Recapitalization exchange ratio					0.9966
Founder shares surrendered (in shares) | shares			9,000,000	9,000,000
Number of trading days | day					10
Number of consecutive trading days | day					20
Earnout period (in years)					5 years
Transaction costs expensed						$ 0	$ 0	$ (7,031,000)	$ 0
Goodwill, tax deductible amount						0		0
Accumulated Amortization						1,519,000		1,519,000
Deferred tax liabilities						$ 28,351,000		$ 28,351,000		$ 0
ViriCiti
Schedule Of Reverse Recapitalization [Line Items]
Cash consideration		$ 79,415,000
Earnout contingent consideration		7,700,000
Acquisition-related expenses		2,200,000
Total purchase consideration		83,323,000
Deferred tax liabilities		$ 3,400,000
HTB
Schedule Of Reverse Recapitalization [Line Items]
Cash consideration	$ 130,134,000
Acquisition-related expenses	2,600,000
Total purchase consideration	232,191,000
Common Stock consideration	$ 102,057,000
Equity transferred (in shares) | shares	5,695,176
Equity transferred (in USD per share) | $ / shares	$ 17.92
Shares held in escrow (in shares) | shares	885,692
Value of shares in escrow	$ 15,900,000
Deferred tax liabilities	$ 25,300,000
Risk-free interest rate | ViriCiti
Schedule Of Reverse Recapitalization [Line Items]
Measurement input		0.008
Expected volatility | ViriCiti
Schedule Of Reverse Recapitalization [Line Items]
Measurement input		0.34
Switchback
Schedule Of Reverse Recapitalization [Line Items]
Recapitalization exchange ratio					0.9966
Recapitalization common stock value (in USD per share) | $ / shares					$ 10
Legacy Chargepoint shares (in shares) | shares					217,021,368
Shares reserved for potential future issuance upon exercise of stock options and warrants (in shares) | shares					68,896,516
Shares reserved for potential future issuance of earnout shares (in shares) | shares					27,000,000
Founder shares surrendered (in shares) | shares					984,706
Additional earn back shares (in shares) | shares					900,000
Earn Back price trigger (USD per share) | $ / shares					$ 12
Number of trading days | day					10
Number of consecutive trading days | day					20
Earnout period (in years)					5 years
Merger and PIPE financing shares (in shares) | shares					60,746,989
Net cash contributions from merger					$ 511,600,000
Cash - Switchback's trust and cash					286,600,000
Repurchase of common stock					300,000
Merger and PIPE financing					225,000,000
Transaction costs expensed					36,500,000
Transaction costs expensed					7,000,000
Switchback | Additional Paid-In Capital
Schedule Of Reverse Recapitalization [Line Items]
Reduction to APIC					$ 29,500,000
Switchback | Private Placement Warrants
Schedule Of Reverse Recapitalization [Line Items]
Debt converted into warrants (in shares) | shares					1,000,000
Stock price of warrants (in dollars per share) | $ / shares					$ 1.50
Converted instrument, principal amount					$ 1,500,000
Switchback | Private Placement
Schedule Of Reverse Recapitalization [Line Items]
Number of shares sold (in shares) | shares					22,500,000
Purchase price per share (USD per share) | $ / shares					$ 10
Consideration received on sold shares					$ 225,000,000
Switchback | Series H-1 Redeemable Convertible Preferred Stock
Schedule Of Reverse Recapitalization [Line Items]
Shares converted (in shares) | shares					22,427,306
Recapitalization exchange ratio					1
Common stock dividends (in shares) | shares					1,026,084
Temporary equity, accrued dividends					$ 21,100,000
Switchback | Series H, Series G, Series F, Series E, And Series D Redeemable Convertible Preferred Stock
Schedule Of Reverse Recapitalization [Line Items]
Shares converted (in shares) | shares					160,925,957
Recapitalization exchange ratio					1
Switchback | Series C Redeemable Convertible Preferred Stock
Schedule Of Reverse Recapitalization [Line Items]
Shares converted (in shares) | shares					45,376
Recapitalization exchange ratio					73.4403
Switchback | Series B Convertible Redeemable Preferred Stock
Schedule Of Reverse Recapitalization [Line Items]
Shares converted (in shares) | shares					130,590
Recapitalization exchange ratio					42.9220
Switchback | Series A Redeemable Convertible Preferred Stock
Schedule Of Reverse Recapitalization [Line Items]
Shares converted (in shares) | shares					29,126
Recapitalization exchange ratio					48.2529

Reverse Recapitalization & Bu_4

Reverse Recapitalization & Business Combinations - Common Stock (Details)	Jun. 29, 2021shares	Mar. 12, 2021shares	Feb. 26, 2021shares	Oct. 31, 2021shares	Apr. 30, 2021shares
Schedule Of Reverse Recapitalization [Line Items]
Common stock, shares outstanding, beginning balance (in shares)					22,961,032
Less surrender of Switchback Founder Shares	(9,000,000)	(9,000,000)
Common stock, shares outstanding, ending balance (in shares)			277,768,357	330,964,104
Common Stock, shares outstanding (in shares)			277,768,357	330,964,104
Recapitalization exchange ratio			0.9966
Switchback
Schedule Of Reverse Recapitalization [Line Items]
Common stock, shares outstanding, beginning balance (in shares)			217,761,738
Less surrender of Switchback Founder Shares			(984,706)
Common stock of switchback (in shares)			38,246,989
Shares issued in PIPE (in shares)			22,500,000
Merger and PIPE financing shares (in shares)			60,746,989
Legacy Chargepoint shares (in shares)			217,021,368
Common stock, shares outstanding, ending balance (in shares)			277,768,357
Additional earn back shares (in shares)			900,000
Common Stock, shares outstanding (in shares)			277,768,357
Recapitalization exchange ratio			0.9966
Switchback | Switchback
Schedule Of Reverse Recapitalization [Line Items]
Common stock, shares outstanding, beginning balance (in shares)			39,264,704
Less redemption of Switchback shares			(33,009)
Common Stock, shares outstanding (in shares)

Reverse Recapitalization & Bu_5

Reverse Recapitalization & Business Combinations - Preliminary Purchase Price Consideration (Details) - USD ($) $ in Thousands	Oct. 06, 2021	Aug. 11, 2021
ViriCiti
Business Acquisition [Line Items]
Cash consideration		$ 79,415
ViriCiti Earnout consideration		3,908
Total purchase consideration		$ 83,323
HTB
Business Acquisition [Line Items]
Cash consideration	$ 130,134
Common Stock consideration	102,057
Total purchase consideration	$ 232,191

Reverse Recapitalization & Bu_6

Reverse Recapitalization & Business Combinations - Preliminary Assets and Liabilities Acquired (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Oct. 06, 2021	Aug. 11, 2021	Jan. 31, 2021
Business Acquisition [Line Items]
Goodwill	$ 200,681			$ 1,215
ViriCiti
Business Acquisition [Line Items]
Cash and cash equivalents			$ 623
Accounts receivable, net			1,248
Other assets			3,215
Goodwill			62,703
Deferred tax liabilities, net			(3,378)
Other liabilities			(5,329)
Total acquired assets and assumed liabilities			83,323
ViriCiti | Customer relationships
Business Acquisition [Line Items]
Intangible assets			17,683
ViriCiti | Developed technology
Business Acquisition [Line Items]
Intangible assets			$ 6,558
HTB
Business Acquisition [Line Items]
Cash and cash equivalents		$ 3,663
Accounts receivable, net		3,764
Other assets		4,259
Goodwill		136,638
Deferred tax liabilities, net		(25,317)
Other liabilities		(10,509)
Total acquired assets and assumed liabilities		232,191
HTB | Customer relationships
Business Acquisition [Line Items]
Intangible assets		103,072
HTB | Developed technology
Business Acquisition [Line Items]
Intangible assets		$ 16,621

Reverse Recapitalization & Bu_7

Reverse Recapitalization & Business Combinations - Pro Forma Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Business Acquisition [Line Items]
Revenue	$ 66,571	$ 38,176	$ 168,736	$ 109,251
Pro forma net loss	(70,559)	(44,807)	(80,708)	(119,334)
HTB
Business Acquisition [Line Items]
An increase in amortization expense	(2,402)	(3,407)	(9,889)	(9,694)
An (increase) decrease in expenses related to transaction	2,556	0	2,556	(2,556)
An (increase) decrease in tax provision	(38)	852	1,833	3,062
Overall (increase) decrease in net loss	116	(2,555)	(5,500)	(9,188)
Pro forma net loss	(1,233)	(1,362)	(3,116)	(3,871)
Chargepoint
Business Acquisition [Line Items]
Pro forma net loss	(69,442)	(40,890)	(72,092)	(106,275)
Chargepoint and HTB
Business Acquisition [Line Items]
Pro forma net loss	$ (70,559)	$ (44,807)	$ (80,708)	$ (119,334)

Reverse Recapitalization & Bu_8

Reverse Recapitalization & Business Combinations - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2021USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 1,215
Foreign exchange fluctuations	125
Ending balance	200,681
ViriCiti
Goodwill [Roll Forward]
Goodwill acquired	62,703
HTB
Goodwill [Roll Forward]
Goodwill acquired	$ 136,638

Reverse Recapitalization & Bu_9

Reverse Recapitalization & Business Combinations - Schedule of Intangible Assets (Details) - USD ($)	9 Months Ended
	Oct. 31, 2021	Jan. 31, 2021
Business Acquisition [Line Items]
Cost	$ 144,058,000
Accumulated amortization	(1,519,000)
Net	142,539,000	$ 0
ViriCiti | Customer relationships
Business Acquisition [Line Items]
Cost	17,683,000
Accumulated amortization	(390,000)
Net	$ 17,293,000
Useful life (in years)	10 years
ViriCiti | Developed technology
Business Acquisition [Line Items]
Cost	$ 6,558,000
Accumulated amortization	(241,000)
Net	$ 6,317,000
Useful life (in years)	6 years
HTB | Customer relationships
Business Acquisition [Line Items]
Cost	$ 103,179,000
Accumulated amortization	(703,000)
Net	$ 102,476,000
Useful life (in years)	10 years
HTB | Developed technology
Business Acquisition [Line Items]
Cost	$ 16,638,000
Accumulated amortization	(185,000)
Net	$ 16,453,000
Useful life (in years)	6 years

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Liabilities
Common stock warrant liabilities	$ 29,282	$ 75,843
Fair Value, Recurring
Assets
Total financial assets	254,714	109,703
Liabilities
Contingent earnout liability recognized upon acquisition of ViriCiti (ViriCiti Earnout)	3,856
Total financial liabilities	33,138	75,843
Fair Value, Recurring | Private Placement Warrants
Liabilities
Common stock warrant liabilities	29,282
Fair Value, Recurring | Redeemable convertible preferred stock warrant liability
Liabilities
Common stock warrant liabilities	75,843
Fair Value, Recurring | Money market funds
Assets
Money market funds	254,714	109,703
Fair Value, Recurring | Level 1
Assets
Total financial assets	254,714	109,703
Liabilities
Contingent earnout liability recognized upon acquisition of ViriCiti (ViriCiti Earnout)	0
Total financial liabilities	0	0
Fair Value, Recurring | Level 1 | Private Placement Warrants
Liabilities
Common stock warrant liabilities	0
Fair Value, Recurring | Level 1 | Redeemable convertible preferred stock warrant liability
Liabilities
Common stock warrant liabilities	0
Fair Value, Recurring | Level 1 | Money market funds
Assets
Money market funds	254,714	109,703
Fair Value, Recurring | Level 2
Assets
Total financial assets	0	0
Liabilities
Contingent earnout liability recognized upon acquisition of ViriCiti (ViriCiti Earnout)	0
Total financial liabilities	0	0
Fair Value, Recurring | Level 2 | Private Placement Warrants
Liabilities
Common stock warrant liabilities	0
Fair Value, Recurring | Level 2 | Redeemable convertible preferred stock warrant liability
Liabilities
Common stock warrant liabilities	0
Fair Value, Recurring | Level 2 | Money market funds
Assets
Money market funds	0	0
Fair Value, Recurring | Level 3
Assets
Total financial assets	0	0
Liabilities
Contingent earnout liability recognized upon acquisition of ViriCiti (ViriCiti Earnout)	3,856
Total financial liabilities	33,138	75,843
Fair Value, Recurring | Level 3 | Private Placement Warrants
Liabilities
Common stock warrant liabilities	29,282
Fair Value, Recurring | Level 3 | Redeemable convertible preferred stock warrant liability
Liabilities
Common stock warrant liabilities	75,843
Fair Value, Recurring | Level 3 | Money market funds
Assets
Money market funds	$ 0	$ 0

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Changes in the Fair Value of Level 3 Financial Instruments (Details) - Level 3 $ in Thousands	9 Months Ended
	Oct. 31, 2021USD ($)
Common stock and preferred stock warrants | Redeemable convertible preferred stock warrant liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 75,843
Change in fair value included in other income (expense), net	9,237
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization	66,606
Ending balance	0
Common stock and preferred stock warrants | Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	0
Private placement warrant liability acquired as part of the merger	(127,888)
Change in fair value included in other income (expense), net	46,835
Reclassification of option warrants to stockholders’ equity (deficit) due to exercise	51,771
Ending balance	29,282
Contingent Consideration Liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	0
Contingent earnout liability recognized upon the closing of the reverse recapitalization	(828,180)
Change in fair value included in other income (expense), net	84,420
Issuance of earnout shares upon triggering events	501,120
Reclassification of remaining contingent earnout liability upon triggering event	242,640
Ending balance	3,856
Contingent Consideration Liability | ViriCiti
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Contingent earnout liability recognized upon the closing of the reverse recapitalization	$ (3,856)

Composition of Certain Financ_3

Composition of Certain Financial Statement Items - Inventories (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 7,489	$ 13,029
Work-in-progress	199	68
Finished goods	22,205	20,495
Total Inventories	$ 29,893	$ 33,592

Composition of Certain Financ_4

Composition of Certain Financial Statement Items - Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020	Jan. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment	$ 67,301		$ 67,301		$ 54,851
Less: Accumulated depreciation	(32,575)		(32,575)		(24,863)
Total Property and Equipment, Net	34,726		34,726		29,988
Depreciation expense	3,100	$ 2,800	8,600	$ 7,500
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment	893		893		1,594
Computers and software
Property, Plant and Equipment [Line Items]
Property and equipment	5,786		5,786		5,384
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property and equipment	14,776		14,776		10,605
Tooling
Property, Plant and Equipment [Line Items]
Property and equipment	10,506		10,506		7,705
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment	10,644		10,644		9,398
Owned and operated systems
Property, Plant and Equipment [Line Items]
Property and equipment	21,236		21,236		17,703
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment	$ 3,460		$ 3,460		$ 2,462

Composition of Certain Financ_5

Composition of Certain Financial Statement Items Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 28,673	$ 18,404
Refundable customer deposits	8,286	6,482
Taxes payable	9,760	5,213
Payroll and related expenses	12,917	7,547
Warranty accruals	3,766	3,000
Operating lease liabilities, current	3,665	2,393
Other liabilities	9,406	4,123
Total Accrued and Other Current Liabilities	$ 76,473	$ 47,162

Composition of Certain Financ_6

Composition of Certain Financial Statement Items - Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Disaggregation of Revenue [Line Items]
Total revenue	$ 65,034	$ 36,365	$ 161,665	$ 104,098
United States
Disaggregation of Revenue [Line Items]
Total revenue	54,561	29,681	139,321	92,319
Rest of World
Disaggregation of Revenue [Line Items]
Total revenue	$ 10,473	$ 6,684	$ 22,344	$ 11,779

Debt (Details)

Debt (Details) - Line of Credit - USD ($)	1 Months Ended		3 Months Ended		9 Months Ended
	Mar. 31, 2021	Jul. 31, 2018	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Debt Instrument [Line Items]
Extinguishment of debt	$ 35,000,000
Interest and prepayment fees	$ 1,200,000
2018 Loan | Medium-term Notes
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 45,000,000
Amount borrowed			$ 35,000,000		$ 35,000,000
Issuance costs			1,100,000		1,100,000
Net proceeds from line of credit		$ 33,900,000
Debt maturity (in years)		5 years
Interest expense			$ 0	$ 800,000	$ 1,500,000	$ 2,400,000
2018 Loan | Medium-term Notes | LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate		6.55%

Commitment and Contingencies -

Commitment and Contingencies - Narrative (Details) $ in Millions	9 Months Ended
	Oct. 31, 2021USD ($)
Commitments and Contingencies Disclosure [Abstract]
Purchase commitments for goods and services	$ 157.8

Commitment and Contingencies _2

Commitment and Contingencies - Future Minimum Lease Payments (Details) - USD ($) $ in Thousands	Oct. 31, 2021	Jan. 31, 2021
Leases, Operating [Abstract]
2022 (remaining three months)	$ 1,680
2023	6,388
2024	5,764
2025	5,328
2026	4,404
Thereafter	14,683
Total undiscounted operating lease payments	38,247
Less: imputed interest	(10,799)
Total operating lease liabilities	27,448
Less: current portion of operating lease liabilities	(3,653)
Operating lease liabilities, noncurrent	$ 23,795	$ 22,459

Common Stock - Narrative (Detai

Common Stock - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	Feb. 26, 2021	Apr. 30, 2021	Oct. 31, 2021	Feb. 25, 2021	Jan. 31, 2021
Equity [Abstract]
Purchase price of merger and PIPE financing shares		$ 200,466
Issuance costs	$ 29,400
Common Stock, shares outstanding (in shares)	277,768,357		330,964,104		22,961,032
Common stock, par value (USD per share)	$ 0.0001		$ 0.0001		$ 0.0001
Shares authorized (in shares)				484,951,532
Common Stock and Preferred Stock, par value (USD per share)				$ 0.0001
Common stock, shares authorized (in shares)			1,000,000,000	299,771,284	299,771,284
Temporary equity, shares authorized (in shares)			0	185,180,248	185,180,248

Common Stock - Reserved for Fut

Common Stock - Reserved for Future Issuance (Details)	Oct. 31, 2021shares
Class of Stock [Line Items]
Total shares of common stock reserved (in shares)	111,132,060
2021 Stock Option Plan
Class of Stock [Line Items]
Total shares of common stock reserved (in shares)	36,436,447
Common Stock Warrants
Class of Stock [Line Items]
Total shares of common stock reserved (in shares)	37,756,829
Options to purchase common stock
Class of Stock [Line Items]
Total shares of common stock reserved (in shares)	24,855,043
Restricted stock units
Class of Stock [Line Items]
Total shares of common stock reserved (in shares)	3,906,058
Employee stock purchase plan
Class of Stock [Line Items]
Total shares of common stock reserved (in shares)	8,177,683

Stock Warrants and Earnouts - N

Stock Warrants and Earnouts - Narrative (Details) $ / shares in Units, $ in Thousands	Jul. 06, 2021$ / sharesshares	Jun. 29, 2021$ / sharesshares	Jun. 04, 2021shares	Mar. 12, 2021USD ($)shares	Feb. 26, 2021USD ($)day$ / sharesshares	Oct. 31, 2021USD ($)shares	Oct. 31, 2021USD ($)shares	Oct. 31, 2020USD ($)	Jul. 01, 2021shares	Mar. 19, 2021USD ($)shares	Feb. 25, 2021shares	Jan. 31, 2021USD ($)shares
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)						37,756,829	37,756,829					38,761,031
Warrants exercised (in shares)							17,751,851
Proceeds from the exercise of warrants | $							$ 118,845	$ 0
Common stock warrant liabilities | $						$ 29,282	$ 29,282					$ 75,843
Warrants redeemed (in shares)							244,481
Earnout period (in years)					5 years
Earnout shares (in shares)				18,000,000	27,000,000
Number of trading days | day					10
Number of consecutive trading days | day					20
Estimated fair value of total earnout shares | $					$ 828,200
Earnout shares, net (in shares)									8,773,596	17,539,657
Derivative liability | $										$ 743,700
Earnout shares remaining (in shares)		9,000,000		9,000,000
Gain from change in fair value | $							$ 84,400
Derivative Instrument, Period One
Class of Warrant or Right [Line Items]
Earn Back price trigger (USD per share) | $ / shares					$ 15
Derivative Instrument, Period Two
Class of Warrant or Right [Line Items]
Earn Back price trigger (USD per share) | $ / shares					20
Derivative Instrument, Period Three
Class of Warrant or Right [Line Items]
Earn Back price trigger (USD per share) | $ / shares					30
Triggering Event, $15 And $20 VWAP Per Share Thresholds
Class of Warrant or Right [Line Items]
Derivative liability | $				$ 501,100
Triggering Event, $15 And $20 VWAP Per Share Thresholds | Minimum
Class of Warrant or Right [Line Items]
Earn Back price trigger (USD per share) | $ / shares					15
Triggering Event, $15 And $20 VWAP Per Share Thresholds | Maximum
Class of Warrant or Right [Line Items]
Earn Back price trigger (USD per share) | $ / shares					20
Triggering Event, $30 VWAP Per Share Threshold
Class of Warrant or Right [Line Items]
Earn Back price trigger (USD per share) | $ / shares		$ 30			$ 30
Derivative liability | $				$ 242,600
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)						2,172,226	2,172,226					0
Warrants exercised (in shares)							4,349,342
Warrants redeemed (in shares)							0
Public Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)						0	0				10,470,562	0
Warrants exercised (in shares)			244,481				10,226,081
Proceeds from the exercise of warrants | $							$ 117,600
Change in fair value of warrant liabilities | $						$ 0	15,900
Common stock warrant liabilities | $						$ 153,700	$ 153,700
Warrants redeemed (in shares)	244,481						244,481
Warrants redeemed price per share (in USD per share) | $ / shares	$ 0.01
Series B, D, And E Redeemable Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)						2,358,528	2,358,528
Legacy Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)						35,584,603	35,584,603					38,761,031
Warrants exercised (in shares)							3,176,428
Proceeds from the exercise of warrants | $						$ 1,200	$ 1,200
Warrants redeemed (in shares)							0
Common Stock Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)						36,402,503	36,402,503
Legacy Common Stock Warrants
Class of Warrant or Right [Line Items]
Warrants exercised (in shares)						1,491,243
Issuance of common stock upon exercise of warrants (in shares)						(1,379,036)	(2,866,560)

Stock Warrants and Earnouts - W

Stock Warrants and Earnouts - Warrant Activity (Details)	Jul. 06, 2021shares	Jun. 04, 2021shares	Oct. 31, 2021shares	Feb. 26, 2021
Warrants Or Rights Outstanding Roll Forward [Roll Forward]
Outstanding at beginning of period (in shares)			38,761,031
Common Stock Warrants as Part of the Merger (in shares)			16,992,130
Warrants exercised (in shares)			(17,751,851)
Warrants redeemed (in shares)			(244,481)
Outstanding at end of period (in shares)			37,756,829
Recapitalization exchange ratio				0.9966
Legacy Warrants
Warrants Or Rights Outstanding Roll Forward [Roll Forward]
Outstanding at beginning of period (in shares)			38,761,031
Common Stock Warrants as Part of the Merger (in shares)			0
Warrants exercised (in shares)			(3,176,428)
Warrants redeemed (in shares)			0
Outstanding at end of period (in shares)			35,584,603
Private Placement Warrants
Warrants Or Rights Outstanding Roll Forward [Roll Forward]
Outstanding at beginning of period (in shares)			0
Common Stock Warrants as Part of the Merger (in shares)			6,521,568
Warrants exercised (in shares)			(4,349,342)
Warrants redeemed (in shares)			0
Outstanding at end of period (in shares)			2,172,226
Public Warrants
Warrants Or Rights Outstanding Roll Forward [Roll Forward]
Outstanding at beginning of period (in shares)			0
Common Stock Warrants as Part of the Merger (in shares)			10,470,562
Warrants exercised (in shares)		(244,481)	(10,226,081)
Warrants redeemed (in shares)	(244,481)		(244,481)
Outstanding at end of period (in shares)			0

Stock Warrants and Earnouts - F

Stock Warrants and Earnouts - Fair Value Inputs of Warrants and Contingent Earnout Liability (Details)	Oct. 31, 2021	Mar. 12, 2021	Feb. 26, 2021	Jan. 31, 2021
Market price of public stock
Class of Warrant or Right [Line Items]
Contingent earnout liability, measurement input		27.84	30.83
Expected term (years)
Class of Warrant or Right [Line Items]
Contingent earnout liability, measurement input		4.96	5
Expected volatility
Class of Warrant or Right [Line Items]
Contingent earnout liability, measurement input		0.7200	0.7160
Risk-free interest rate
Class of Warrant or Right [Line Items]
Contingent earnout liability, measurement input		0.0085	0.0075
Dividend rate
Class of Warrant or Right [Line Items]
Contingent earnout liability, measurement input		0	0
Redeemable convertible preferred stock warrant liability | Expected term (years)
Class of Warrant or Right [Line Items]
Warrants, measurement input			0	1.4
Redeemable convertible preferred stock warrant liability | Expected volatility
Class of Warrant or Right [Line Items]
Warrants, measurement input			0.843	0.805
Redeemable convertible preferred stock warrant liability | Risk-free interest rate
Class of Warrant or Right [Line Items]
Warrants, measurement input			0	0.001
Redeemable convertible preferred stock warrant liability | Dividend rate
Class of Warrant or Right [Line Items]
Warrants, measurement input			0	0
Private Placement Warrants | Market price of public stock
Class of Warrant or Right [Line Items]
Warrants, measurement input	24.78		30.83
Private Placement Warrants | Exercise price
Class of Warrant or Right [Line Items]
Warrants, measurement input	11.50		11.50
Private Placement Warrants | Expected term (years)
Class of Warrant or Right [Line Items]
Warrants, measurement input	4.3		5
Private Placement Warrants | Expected volatility
Class of Warrant or Right [Line Items]
Warrants, measurement input	0.705		0.735
Private Placement Warrants | Risk-free interest rate
Class of Warrant or Right [Line Items]
Warrants, measurement input	0.010		0.008
Private Placement Warrants | Dividend rate
Class of Warrant or Right [Line Items]
Warrants, measurement input	0		0

Equity Plans and Stock-based _3

Equity Plans and Stock-based Compensation - Narrative (Details) - USD ($) $ in Millions	Feb. 25, 2021	Jun. 30, 2021	Oct. 31, 2021
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Common stock reserved (in shares)			111,132,060
Period for recognition (in years)			2 years 7 months 6 days
Unrecognized stock-based compensation cost			$ 125.2
Employee stock purchase plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Common stock reserved (in shares)			8,177,683
Eligible compensation per employee (as a percent)			15.00%
Offering period (in months)			24 months
Purchase period (in months)			6 months
Purchase price of common stock, percent of fair value			85.00%
Maximum number of shares to be purchased per employee (in shares)			10,000
Restricted stock units
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Common stock reserved (in shares)			3,906,058
Options to purchase common stock
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Common stock reserved (in shares)			24,855,043
2021 Equity Incentive Plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Possible increase in percent of outstanding shares (as a percent)	1.00%
Number of additional shares allowable under the plan (in shares)	5,400,000
Percent of outstanding shares (as a percent)	5.00%
2017 Stock Plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Common stock reserved (in shares)			21,412,248
2017 Stock Plan | Chief Executive Officer
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Number of stock options granted (in shares)		1,500,000
Unrecognized compensation expense			$ 31.7
2017 Stock Plan | Options to purchase common stock | Chief Executive Officer
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Period for recognition (in years)			2 years 3 months
2007 Stock Plan
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]
Common stock reserved (in shares)			3,442,795

Equity Plans and Stock-based _4

Equity Plans and Stock-based Compensation - Stock Option Activity (Details) - USD ($)	9 Months Ended	12 Months Ended
	Oct. 31, 2021	Jan. 31, 2021
Number of Stock Option Awards
Outstanding as of beginning of period (in shares)	30,166,792
Options exercised (in shares)	(4,666,083)
Forfeited (in shares)	(624,618)
Expired (in shares)	(21,048)
Outstanding as end of period (in shares)	24,855,043	30,166,792
Options vested and expected to vest at end of period (in shares)	24,314,890
Exercisable at end of period (in shares)	16,523,251
Weighted Average Exercise Price
Outstanding as of beginning of period (USD per share)	$ 0.71
Options exercised (USD per share)	0.59
Forfeited (USD per share)	0.74
Expired (USD per share)	53.26
Outstanding as of end of period (USD per share)	0.69	$ 0.71
Options vested and expected to vest as of end of period (USD per share)	0.68
Exercisable as of end of period (USD per share)	$ 0.66
Weighted Average Remaining Contractual term (in years)
Outstanding (in years)	6 years 9 months 18 days	7 years 3 months 18 days
Options vested and expected to ves (in years)	6 years 8 months 12 days
Exercisable (in years)	6 years 2 months 12 days
Aggregate Intrinsic Value (in thousands)
Outstanding	$ 598,912	$ 1,064,539
Options vested and expected to vest	585,934
Exercisable	$ 398,582

Common Stock and Stockholders'

Common Stock and Stockholders' Equity - Restricted Stock Units Activity (Details) - Restricted stock units	9 Months Ended
	Oct. 31, 2021$ / sharesshares
Number of Shares
Outstanding, beginning balance (in shares) | shares	0
Granted (in shares) | shares	5,042,559
Vested (in shares) | shares	(1,019,817)
Forfeited (in shares) | shares	(116,684)
Outstanding, ending balance (in shares) | shares	3,906,058
Weighted Average Grant Date Fair Value per Share
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	26.94
Vested (in dollars per share) | $ / shares	27.36
Forfeited (in dollars per share) | $ / shares	27.17
Outstanding, ending balance (in dollars per share) | $ / shares	$ 26.82

Equity Plans and Stock-based _5

Equity Plans and Stock-based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 16,022	$ 1,208	$ 51,893	$ 3,308
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	5,840	448	20,198	1,205
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	2,251	333	7,018	988
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	7,046	398	21,604	1,022
Cost Of Goods And Services Sold
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 885	$ 29	$ 3,073	$ 93

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Income Tax Disclosure [Abstract]
Effective income tax rate	0.00%	0.00%	0.00%	0.00%
Deferred tax benefit			$ (370)	$ 0

Related Party Transactions - Sc

Related Party Transactions - Schedule of Revenue Transactions (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Related Party Transaction [Line Items]
Revenue from related parties	$ 1,290,000	$ 953,000	$ 4,696,000	$ 2,529,000
Daimler
Related Party Transaction [Line Items]
Revenue from related parties	$ 1,290,000	$ 953,000	$ 4,696,000	$ 2,529,000

Related Party Transactions - Na

Related Party Transactions - Narrative (Details) - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Daimler
Related Party Transaction [Line Items]
Related party accounts receivable	$ 2.3	$ 1.2

Basic and Diluted Net Loss pe_3

Basic and Diluted Net Loss per Share - Computation of Basic and Diluted Loss per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2021	Oct. 31, 2020	Jul. 31, 2020	Apr. 30, 2020	Oct. 31, 2021	Oct. 31, 2020
Numerator:
Net loss	$ (69,442)	$ (84,938)	$ 82,289	$ (40,890)	$ (35,287)	$ (30,098)	$ (72,092)	$ (106,275)
Accretion of beneficial conversion feature of redeemable convertible preferred stock	0			(1,752)			0	(60,377)
Cumulative dividends on redeemable convertible preferred stock	0			(3,960)			(4,292)	(3,960)
Deemed dividends attributable to vested option holders	0			0			(51,855)	0
Deemed dividends attributable to common stock warrant holders	0			0			(110,635)	0
Net loss attributable to common stockholders - Basic	(69,442)			(46,602)			(238,874)	(170,612)
Gain attributable to earnout shares issued	0			0			(84,420)	0
Change in fair value of dilutive warrants	0			0			(51,106)	0
Net loss attributable to common stockholders - Diluted	$ (69,442)			$ (46,602)			$ (374,400)	$ (170,612)
Denominator:
Weighted average common shares outstanding (in shares)	325,223,132			15,102,625			286,272,045	13,550,552
Less: Weighted-average unvested restricted shares and shares subject to repurchase (in shares)	(188,212)			(111,759)			(246,562)	0
Weighted average shares outstanding - Basic (in shares)	325,034,920			14,990,866			286,025,483	13,550,552
Add: Earnout Shares under the treasury stock method (in shares)	0			0			4,948,794	0
Add: Public and Private Placement Warrants under the treasury stock method (in shares)	0			0			1,601,041	0
Weighted average shares outstanding - Diluted (in shares)	325,034,920			14,990,866			292,575,318	13,550,552
Net loss per share - Basic (USD per share)	$ (0.21)			$ (3.11)			$ (0.84)	$ (12.59)
Net loss per share - Diluted (USD per share)	$ (0.21)			$ (3.11)			$ (1.28)	$ (12.59)

Basic and Diluted Net Loss pe_4

Basic and Diluted Net Loss per Share - Narrative (Details)	Feb. 26, 2021
Earnings Per Share [Abstract]
Recapitalization exchange ratio	0.9966

Basic and Diluted Net Loss pe_5

Basic and Diluted Net Loss per Share - Antidilutive Securities (Details) - shares	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	65,452,817	269,922,805
Redeemable convertible preferred stock (on an as-converted basis)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	0	193,484,162
Options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	24,855,043	37,547,865
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	3,906,058	0
Unvested early exercised common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	164,778	129,717
Common stock and preferred stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	35,584,603	38,761,061
Employee stock purchase plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common share equivalents	942,335	0

Uncategorized Items - chpt-2021

Label	Element	Value
Additional Paid-in Capital [Member]
Stock Issued During Period, Value, Reverse Recapitalization	chpt_StockIssuedDuringPeriodValueReverseRecapitalization	$ 200,500,000